activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650414	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4014	Homo sapiens	Kd		
Not Active	1650414	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4014	Homo sapiens	Kd		
	1650415	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	160.0	CHEMBL4014	Homo sapiens	Kd	uM	0.16
Not Active	1650416	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4014	Homo sapiens	Kd		
	1650417	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1200.0	CHEMBL4014	Homo sapiens	Kd	uM	1.2
Not Active	1650418	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4014	Homo sapiens	Kd		
Not Active	1650419	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4014	Homo sapiens	Kd		
	1650420	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1300.0	CHEMBL4014	Homo sapiens	Kd	uM	1.3
Not Active	1650421	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4014	Homo sapiens	Kd		
Not Active	1650422	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4014	Homo sapiens	Kd		
	1651258	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	160.0	CHEMBL4014	Homo sapiens	Kd	uM	0.16
Not Active	1651259	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4014	Homo sapiens	Kd		
Not Active	1651260	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4014	Homo sapiens	Kd		
	1651261	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	220.0	CHEMBL4014	Homo sapiens	Kd	uM	0.22
Not Active	1651262	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4014	Homo sapiens	Kd		
Not Active	1651263	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL4014	Homo sapiens	Kd		
	1651264	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	13.0	CHEMBL4014	Homo sapiens	Kd	uM	0.013
Not Active	1651265	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4014	Homo sapiens	Kd		
	1651266	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	300.0	CHEMBL4014	Homo sapiens	Kd	uM	0.3
	1651267	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	130.0	CHEMBL4014	Homo sapiens	Kd	uM	0.13
	1651268	CHEMBL860899	Average Binding Constant for ABL2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1300.0	CHEMBL4014	Homo sapiens	Kd	uM	1.3
	1727535	CHEMBL859731	Inhibition of human Arg kinase at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Inhibition	%	49.0	CHEMBL4014	Homo sapiens	Inhibition	%	49.0
	1769377	CHEMBL910897	Inhibition of Arg kinase	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL4014	Homo sapiens	IC50	uM	1.0
	2050261	CHEMBL925559	Inhibition of Arg at 1 uM	B	CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1	Outside typical range	CHEMBL400754	=	Inhibition	%	-15.0	CHEMBL4014	Homo sapiens	Inhibition	%	-15.0
	2147190	CHEMBL927934	Activity of human Arg kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	40.0	CHEMBL4014	Homo sapiens	Activity	%	40.0
	2470095	CHEMBL1032237	Inhibition of ABL2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4014	Homo sapiens	INH	%	10.0
	2476602	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	13.4	CHEMBL4014	Homo sapiens	Activity	%	13.4
Not Evaluated	2476805	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4014	Homo sapiens	Activity		
Not Evaluated	2478644	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4014	Homo sapiens	Activity		
Not Evaluated	2478847	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4014	Homo sapiens	Activity		
	2479553	CHEMBL988945	Binding affinity to human ARG	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Kd	nM	1870.0	CHEMBL4014	Homo sapiens	Kd	nM	1870.0
Not Evaluated	2479702	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4014	Homo sapiens	Activity		
	2480701	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	4.8	CHEMBL4014	Homo sapiens	Activity	%	4.8
	2526443	CHEMBL981439	Binding affinity to Abl2	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4.0	CHEMBL4014	Homo sapiens	Kd	nM	4.0
Not Evaluated	2577323	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4014	Homo sapiens	Activity		
Not Evaluated	2577526	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4014	Homo sapiens	Activity		
Active	2593528	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4014	Homo sapiens	Activity		
Active	2593731	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4014	Homo sapiens	Activity		
	2593997	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.4	CHEMBL4014	Homo sapiens	Activity	%	0.4
Not Evaluated	2594940	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4014	Homo sapiens	Activity		
Not Evaluated	2595143	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4014	Homo sapiens	Activity		
	2595209	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	15.8	CHEMBL4014	Homo sapiens	Activity	%	15.8
	2596340	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	0.1	CHEMBL4014	Homo sapiens	Activity	%	0.1
	2597609	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	4.1	CHEMBL4014	Homo sapiens	Activity	%	4.1
	2597812	CHEMBL1035866	Binding affinity to human ARG at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Activity	%	1.4	CHEMBL4014	Homo sapiens	Activity	%	1.4
	2721550	CHEMBL1060958	Inhibition of Arg at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	2895505	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895506	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895507	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3.4	CHEMBL4014	Homo sapiens	Kd	nM	3.4
	2895508	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895509	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895510	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895511	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895512	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1900.0	CHEMBL4014	Homo sapiens	Kd	nM	1900.0
	2895513	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	870.0	CHEMBL4014	Homo sapiens	Kd	nM	870.0
	2895514	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895515	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895516	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.17	CHEMBL4014	Homo sapiens	Kd	nM	0.17
	2895517	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	370.0	CHEMBL4014	Homo sapiens	Kd	nM	370.0
	2895518	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	200.0	CHEMBL4014	Homo sapiens	Kd	nM	200.0
	2895519	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895520	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895521	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895522	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	3000.0	CHEMBL4014	Homo sapiens	Kd	nM	3000.0
	2895523	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	10.0	CHEMBL4014	Homo sapiens	Kd	nM	10.0
	2895524	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895525	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895526	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895527	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895528	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3300.0	CHEMBL4014	Homo sapiens	Kd	nM	3300.0
	2895529	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895530	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895531	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895532	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895533	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895534	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895535	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895536	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2900.0	CHEMBL4014	Homo sapiens	Kd	nM	2900.0
	2895537	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	110.0	CHEMBL4014	Homo sapiens	Kd	nM	110.0
	2895538	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	2895539	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1000.0	CHEMBL4014	Homo sapiens	Kd	nM	1000.0
	2895540	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4.0	CHEMBL4014	Homo sapiens	Kd	nM	4.0
	2895541	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	1900.0	CHEMBL4014	Homo sapiens	Kd	nM	1900.0
	2895542	CHEMBL1061131	Binding constant for ABL2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	69.0	CHEMBL4014	Homo sapiens	Kd	nM	69.0
	2921452	CHEMBL1057559	Inhibition of ABL2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	42.0	CHEMBL4014	Homo sapiens	Activity	%	42.0
	2928459	CHEMBL1049957	Binding affinity to ABL2 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	0.75	CHEMBL4014	Homo sapiens	Activity	%	0.75
	3052518	CHEMBL1047769	Residual activity of ABL2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	87.0	CHEMBL4014	Homo sapiens	Residual activity	%	87.0
	3052770	CHEMBL1043849	Residual activity of ABL2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL4014	Homo sapiens	Residual activity	%	93.0
	3054079	CHEMBL1066597	Residual activity of ABL2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	100.0	CHEMBL4014	Homo sapiens	Residual activity	%	100.0
	3055366	CHEMBL1047769	Residual activity of ABL2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	99.0	CHEMBL4014	Homo sapiens	Residual activity	%	99.0
	3055618	CHEMBL1043849	Residual activity of ABL2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	170.0	CHEMBL4014	Homo sapiens	Residual activity	%	170.0
	3056923	CHEMBL1066597	Residual activity of ABL2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	116.0	CHEMBL4014	Homo sapiens	Residual activity	%	116.0
	3058243	CHEMBL1047769	Residual activity of ABL2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	98.0	CHEMBL4014	Homo sapiens	Residual activity	%	98.0
	3058495	CHEMBL1043849	Residual activity of ABL2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	147.0	CHEMBL4014	Homo sapiens	Residual activity	%	147.0
	3072841	CHEMBL1066597	Residual activity of ABL2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	96.0	CHEMBL4014	Homo sapiens	Residual activity	%	96.0
	3213781	CHEMBL1107585	Inhibition of ARG at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	102.0	CHEMBL4014	Homo sapiens	INH	%	102.0
	3224753	CHEMBL1102590	Inhibition of ABL2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3224998	CHEMBL1102590	Inhibition of ABL2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3331814	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3333229	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3334634	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3336054	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Inhibition	%	83.0	CHEMBL4014	Homo sapiens	INH	%	83.0
	3337440	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3337688	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3339019	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3339275	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	75.9	CHEMBL4014	Homo sapiens	INH	%	75.9
	3340582	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3341998	CHEMBL1168581	Inhibition of ABL2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3358441	CHEMBL1174055	Inhibition of ABL2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.05	CHEMBL4014	Homo sapiens	INH	%	0.05
	3358883	CHEMBL1174055	Inhibition of ABL2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL4014	Homo sapiens	INH	%	0.0
	3443332	CHEMBL1243984	Inhibition of ABL2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	98.0	CHEMBL4014	Homo sapiens	INH	%	98.0
	3443549	CHEMBL1243984	Inhibition of ABL2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	97.0	CHEMBL4014	Homo sapiens	INH	%	97.0
	3444704	CHEMBL1243984	Inhibition of ABL2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	70.0	CHEMBL4014	Homo sapiens	INH	%	70.0
	3445328	CHEMBL1243984	Inhibition of ABL2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	3445545	CHEMBL1243984	Inhibition of ABL2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	22.0	CHEMBL4014	Homo sapiens	INH	%	22.0
	3445763	CHEMBL1243984	Inhibition of ABL2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	97.0	CHEMBL4014	Homo sapiens	INH	%	97.0
	3445953	CHEMBL1243984	Inhibition of ABL2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	58.0	CHEMBL4014	Homo sapiens	INH	%	58.0
	3446186	CHEMBL1244324	Inhibition of ABL2	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	0.5	CHEMBL4014	Homo sapiens	IC50	nM	0.5
	3448684	CHEMBL1244711	Binding affinity to ABL2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	3449390	CHEMBL1244711	Binding affinity to ABL2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1000.0	CHEMBL4014	Homo sapiens	Kd	nM	1000.0
	3449391	CHEMBL1244711	Binding affinity to ABL2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2900.0	CHEMBL4014	Homo sapiens	Kd	nM	2900.0
	3449547	CHEMBL1244711	Binding affinity to ABL2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	3449906	CHEMBL1244711	Binding affinity to ABL2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	3449973	CHEMBL1244711	Binding affinity to ABL2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	3450901	CHEMBL1244711	Binding affinity to ABL2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	uM	10.0
	3463165	CHEMBL1251625	Inhibition of ABL2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	6.0	CHEMBL4014	Homo sapiens	INH	%	6.0
	3463384	CHEMBL1251625	Inhibition of ABL2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	4.0	CHEMBL4014	Homo sapiens	INH	%	4.0
	3463928	CHEMBL1251625	Inhibition of ABL2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	37.0	CHEMBL4014	Homo sapiens	INH	%	37.0
	3590796	CHEMBL1292129	Inhibition of human ABL2	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Outside typical range	CHEMBL1290072	>	Ki	nM	1000000.0	CHEMBL4014	Homo sapiens	Ki	uM	1000.0
	5120413	CHEMBL1648172	Inhibition of human Arg at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	109.0	CHEMBL4014	Homo sapiens	INH	%	109.0
	6155508	CHEMBL1764253	Inhibition of Abl2 at 20 uM after 1 hr by luminescence assay	B	O=C(CN[C@H]1CCN(S(=O)(=O)Cc2ccccc2)C1)N1CCN(Cc2cccc(C(F)(F)F)c2)CC1		CHEMBL1760997	=	Inhibition	%	4.49	CHEMBL4014	Homo sapiens	INH	%	4.49
	6155509	CHEMBL1764253	Inhibition of Abl2 at 20 uM after 1 hr by luminescence assay	B	Cc1cc(C)c(CN2CCN(C(=O)CN[C@H]3CCN(S(=O)(=O)Cc4ccccc4)C3)CC2)c(C)c1		CHEMBL1760998	=	Inhibition	%	1.39	CHEMBL4014	Homo sapiens	INH	%	1.39
	6155510	CHEMBL1764253	Inhibition of Abl2 at 20 uM after 1 hr by luminescence assay	B	O=C(CN[C@H]1CCN(S(=O)(=O)Cc2ccccc2)C1)N1CCN(Cc2ccc(Cl)cc2Cl)CC1		CHEMBL1761145	=	Inhibition	%	4.92	CHEMBL4014	Homo sapiens	INH	%	4.92
	6155511	CHEMBL1764253	Inhibition of Abl2 at 20 uM after 1 hr by luminescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	90.2	CHEMBL4014	Homo sapiens	INH	%	90.2
	6167591	CHEMBL1769234	Binding affinity to human ABL2 phenylalanine residue assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	49.0	CHEMBL4014	Homo sapiens	Activity	%	49.0
	6167615	CHEMBL1768475	Binding affinity to human ABL2 phenylalanine residue assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	0.4	CHEMBL4014	Homo sapiens	Activity	%	0.4
	6174264	CHEMBL1767522	Binding affinity to human active site of N-terminal hexahistidine-tagged ABL2 expressed in Trichoplusia ni infected Sf9 cells by isothermal titration calorimetric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	6.0	CHEMBL4014	Homo sapiens	Kd	nM	6.0
	6174265	CHEMBL1767523	Binding affinity to human remote site of N-terminal hexahistidine-tagged ABL2 expressed in Trichoplusia ni infected Sf9 cells by isothermal titration calorimetric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	500.0	CHEMBL4014	Homo sapiens	Kd	uM	0.5
	6341010	CHEMBL1827635	Activity of ABL2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4014	Homo sapiens	Activity	%	100.0
	7567391	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	730.0	CHEMBL4014	Homo sapiens	Kd	nM	730.0
	7567850	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7567879	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7568347	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	0.69	CHEMBL4014	Homo sapiens	Kd	nM	0.69
	7568779	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7569364	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7569854	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	10.0	CHEMBL4014	Homo sapiens	Kd	nM	10.0
	7570317	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	6900.0	CHEMBL4014	Homo sapiens	Kd	nM	6900.0
	7570744	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1000.0	CHEMBL4014	Homo sapiens	Kd	nM	1000.0
	7571355	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	460.0	CHEMBL4014	Homo sapiens	Kd	nM	460.0
	7571831	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7572294	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7572710	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	380.0	CHEMBL4014	Homo sapiens	Kd	nM	380.0
	7572879	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7573336	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.17	CHEMBL4014	Homo sapiens	Kd	nM	0.17
	7573812	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	5300.0	CHEMBL4014	Homo sapiens	Kd	nM	5300.0
	7574281	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7574689	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7574857	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	2000.0	CHEMBL4014	Homo sapiens	Kd	nM	2000.0
	7575318	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	200.0	CHEMBL4014	Homo sapiens	Kd	nM	200.0
	7575789	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	950.0	CHEMBL4014	Homo sapiens	Kd	nM	950.0
	7576254	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	2700.0	CHEMBL4014	Homo sapiens	Kd	nM	2700.0
	7576662	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	570.0	CHEMBL4014	Homo sapiens	Kd	nM	570.0
	7576831	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7577290	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	27.0	CHEMBL4014	Homo sapiens	Kd	nM	27.0
	7577768	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	250.0	CHEMBL4014	Homo sapiens	Kd	nM	250.0
	7578839	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7579213	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1300.0	CHEMBL4014	Homo sapiens	Kd	nM	1300.0
	7579663	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7580137	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7580164	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1200.0	CHEMBL4014	Homo sapiens	Kd	nM	1200.0
	7580567	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	69.0	CHEMBL4014	Homo sapiens	Kd	nM	69.0
	7581197	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	110.0	CHEMBL4014	Homo sapiens	Kd	nM	110.0
	7581582	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7582027	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7582520	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7582920	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4.0	CHEMBL4014	Homo sapiens	Kd	nM	4.0
	7583543	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7583940	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7584414	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7584876	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	720.0	CHEMBL4014	Homo sapiens	Kd	nM	720.0
	7585280	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	1900.0	CHEMBL4014	Homo sapiens	Kd	nM	1900.0
	7585873	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7586285	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7586756	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7587210	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7587811	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	1800.0	CHEMBL4014	Homo sapiens	Kd	nM	1800.0
	7588264	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	1600.0	CHEMBL4014	Homo sapiens	Kd	nM	1600.0
	7588735	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7589186	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7589357	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	70.0	CHEMBL4014	Homo sapiens	Kd	nM	70.0
	7589781	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	6500.0	CHEMBL4014	Homo sapiens	Kd	nM	6500.0
	7590248	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7590722	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7591173	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7591330	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	4500.0	CHEMBL4014	Homo sapiens	Kd	nM	4500.0
	7591752	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7592224	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7592697	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3300.0	CHEMBL4014	Homo sapiens	Kd	nM	3300.0
	7593150	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.5	CHEMBL4014	Homo sapiens	Kd	nM	1.5
	7593297	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3.4	CHEMBL4014	Homo sapiens	Kd	nM	3.4
	7593732	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1900.0	CHEMBL4014	Homo sapiens	Kd	nM	1900.0
	7594204	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7594677	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	26.0	CHEMBL4014	Homo sapiens	Kd	nM	26.0
	7595265	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7595709	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	870.0	CHEMBL4014	Homo sapiens	Kd	nM	870.0
	7596183	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7596659	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2900.0	CHEMBL4014	Homo sapiens	Kd	nM	2900.0
	7597237	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7597690	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4014	Homo sapiens	Kd	nM	10000.0
	7598191	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	3000.0	CHEMBL4014	Homo sapiens	Kd	nM	3000.0
	7598633	CHEMBL1908690	Binding constant for ABL2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	110.0	CHEMBL4014	Homo sapiens	Kd	nM	110.0
	7931065	CHEMBL1919071	Inhibition of ABL2 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	65.0	CHEMBL4014	Homo sapiens	INH	%	65.0
	7959661	CHEMBL1932271	Inhibition of ABL2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4014	Homo sapiens	IC50	uM	30.0
	7959662	CHEMBL1932271	Inhibition of ABL2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL4014	Homo sapiens	IC50	uM	30.0
	7996672	CHEMBL1944003	Inhibition of ABL2 at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	93.0	CHEMBL4014	Homo sapiens	INH	%	93.0
	8046136	CHEMBL1958809	Inhibition of ABL2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	8061355	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	9.17	CHEMBL4014	Homo sapiens	Inhibition	%	9.17
	8061532	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	49.24	CHEMBL4014	Homo sapiens	Inhibition	%	49.24
	8061863	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	10.24	CHEMBL4014	Homo sapiens	Inhibition	%	10.24
	8062054	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.71	CHEMBL4014	Homo sapiens	Inhibition	%	3.71
	8062394	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.62	CHEMBL4014	Homo sapiens	Inhibition	%	2.62
	8062556	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.33	CHEMBL4014	Homo sapiens	Inhibition	%	4.33
	8062878	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.97	CHEMBL4014	Homo sapiens	Inhibition	%	-1.97
	8063234	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	55.78	CHEMBL4014	Homo sapiens	Inhibition	%	55.78
	8063401	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.64	CHEMBL4014	Homo sapiens	Inhibition	%	2.64
	8063733	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.95	CHEMBL4014	Homo sapiens	Inhibition	%	1.95
	8063915	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	20.93	CHEMBL4014	Homo sapiens	Inhibition	%	20.93
	8064254	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.75	CHEMBL4014	Homo sapiens	Inhibition	%	7.75
	8064464	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.71	CHEMBL4014	Homo sapiens	Inhibition	%	1.71
	8064826	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	9.21	CHEMBL4014	Homo sapiens	Inhibition	%	9.21
	8064992	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	9.44	CHEMBL4014	Homo sapiens	Inhibition	%	9.44
	8065332	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.03	CHEMBL4014	Homo sapiens	Inhibition	%	6.03
	8065507	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.21	CHEMBL4014	Homo sapiens	Inhibition	%	4.21
	8065731	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	32.13	CHEMBL4014	Homo sapiens	Inhibition	%	32.13
	8065846	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.48	CHEMBL4014	Homo sapiens	Inhibition	%	2.48
	8066056	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	8.08	CHEMBL4014	Homo sapiens	Inhibition	%	8.08
	8066280	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.12	CHEMBL4014	Homo sapiens	Inhibition	%	2.12
	8066416	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	57.15	CHEMBL4014	Homo sapiens	Inhibition	%	57.15
	8066582	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.81	CHEMBL4014	Homo sapiens	Inhibition	%	2.81
	8066806	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	8.05	CHEMBL4014	Homo sapiens	Inhibition	%	8.05
	8066930	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	16.06	CHEMBL4014	Homo sapiens	Inhibition	%	16.06
	8067329	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	5.17	CHEMBL4014	Homo sapiens	Inhibition	%	5.17
	8067450	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.42	CHEMBL4014	Homo sapiens	Inhibition	%	2.42
	8067674	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.94	CHEMBL4014	Homo sapiens	Inhibition	%	3.94
	8067884	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	9.26	CHEMBL4014	Homo sapiens	Inhibition	%	9.26
	8068019	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	10.46	CHEMBL4014	Homo sapiens	Inhibition	%	10.46
	8068407	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	4.38	CHEMBL4014	Homo sapiens	Inhibition	%	4.38
	8068532	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	34.36	CHEMBL4014	Homo sapiens	Inhibition	%	34.36
	8068756	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.54	CHEMBL4014	Homo sapiens	Inhibition	%	3.54
	8068930	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	6.34	CHEMBL4014	Homo sapiens	Inhibition	%	6.34
	8069279	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	7.98	CHEMBL4014	Homo sapiens	Inhibition	%	7.98
	8069350	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	69.6	CHEMBL4014	Homo sapiens	Inhibition	%	69.6
	8069574	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	10.99	CHEMBL4014	Homo sapiens	Inhibition	%	10.99
	8069735	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	20.28	CHEMBL4014	Homo sapiens	Inhibition	%	20.28
	8070085	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.41	CHEMBL4014	Homo sapiens	Inhibition	%	2.41
	8070257	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.63	CHEMBL4014	Homo sapiens	Inhibition	%	2.63
	8070606	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	8.41	CHEMBL4014	Homo sapiens	Inhibition	%	8.41
	8070904	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	57.29	CHEMBL4014	Homo sapiens	Inhibition	%	57.29
	8071061	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.13	CHEMBL4014	Homo sapiens	Inhibition	%	3.13
	8071411	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.75	CHEMBL4014	Homo sapiens	Inhibition	%	3.75
	8071584	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	9.3	CHEMBL4014	Homo sapiens	Inhibition	%	9.3
	8071808	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.57	CHEMBL4014	Homo sapiens	Inhibition	%	3.57
	8071933	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	16.57	CHEMBL4014	Homo sapiens	Inhibition	%	16.57
	8072247	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	4.08	CHEMBL4014	Homo sapiens	Inhibition	%	4.08
	8072404	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	7.59	CHEMBL4014	Homo sapiens	Inhibition	%	7.59
	8072628	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	9.07	CHEMBL4014	Homo sapiens	Inhibition	%	9.07
	8072753	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	8.0	CHEMBL4014	Homo sapiens	Inhibition	%	8.0
	8073144	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	18.39	CHEMBL4014	Homo sapiens	Inhibition	%	18.39
	8073269	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	51.42	CHEMBL4014	Homo sapiens	Inhibition	%	51.42
	8073612	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.63	CHEMBL4014	Homo sapiens	Inhibition	%	3.63
	8073845	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	41.3	CHEMBL4014	Homo sapiens	Inhibition	%	41.3
	8074221	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	16.79	CHEMBL4014	Homo sapiens	Inhibition	%	16.79
	8074351	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	4.85	CHEMBL4014	Homo sapiens	Inhibition	%	4.85
	8074575	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	11.82	CHEMBL4014	Homo sapiens	Inhibition	%	11.82
	8074732	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.21	CHEMBL4014	Homo sapiens	Inhibition	%	2.21
	8074859	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	73.6	CHEMBL4014	Homo sapiens	Inhibition	%	73.6
	8075083	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.93	CHEMBL4014	Homo sapiens	Inhibition	%	4.93
	8075194	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	12.05	CHEMBL4014	Homo sapiens	Inhibition	%	12.05
	8075431	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.08	CHEMBL4014	Homo sapiens	Inhibition	%	2.08
	8075655	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	5.65	CHEMBL4014	Homo sapiens	Inhibition	%	5.65
	8075796	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.74	CHEMBL4014	Homo sapiens	Inhibition	%	3.74
	8076162	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.37	CHEMBL4014	Homo sapiens	Inhibition	%	4.37
	8076310	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.93	CHEMBL4014	Homo sapiens	Inhibition	%	2.93
	8076668	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	8.07	CHEMBL4014	Homo sapiens	Inhibition	%	8.07
	8076770	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.71	CHEMBL4014	Homo sapiens	Inhibition	%	1.71
	8076994	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	5.07	CHEMBL4014	Homo sapiens	Inhibition	%	5.07
	8077241	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.15	CHEMBL4014	Homo sapiens	Inhibition	%	1.15
	8077369	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-0.4	CHEMBL4014	Homo sapiens	Inhibition	%	-0.4
	8077744	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.94	CHEMBL4014	Homo sapiens	Inhibition	%	2.94
	8077887	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.26	CHEMBL4014	Homo sapiens	Inhibition	%	2.26
	8078250	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.56	CHEMBL4014	Homo sapiens	Inhibition	%	0.56
	8078576	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.12	CHEMBL4014	Homo sapiens	Inhibition	%	2.12
	8078826	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	6.91	CHEMBL4014	Homo sapiens	Inhibition	%	6.91
	8078942	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.17	CHEMBL4014	Homo sapiens	Inhibition	%	4.17
	8079166	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	6.56	CHEMBL4014	Homo sapiens	Inhibition	%	6.56
	8079324	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.97	CHEMBL4014	Homo sapiens	Inhibition	%	0.97
	8079466	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	8.26	CHEMBL4014	Homo sapiens	Inhibition	%	8.26
	8079690	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.02	CHEMBL4014	Homo sapiens	Inhibition	%	3.02
	8079829	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	16.87	CHEMBL4014	Homo sapiens	Inhibition	%	16.87
	8080158	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	6.46	CHEMBL4014	Homo sapiens	Inhibition	%	6.46
	8080410	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	3.59	CHEMBL4014	Homo sapiens	Inhibition	%	3.59
	8080749	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.72	CHEMBL4014	Homo sapiens	Inhibition	%	2.72
	8080913	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	7.64	CHEMBL4014	Homo sapiens	Inhibition	%	7.64
	8081272	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.87	CHEMBL4014	Homo sapiens	Inhibition	%	3.87
	8081416	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.8	CHEMBL4014	Homo sapiens	Inhibition	%	2.8
	8081743	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.29	CHEMBL4014	Homo sapiens	Inhibition	%	2.29
	8081995	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	20.35	CHEMBL4014	Homo sapiens	Inhibition	%	20.35
	8082332	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.53	CHEMBL4014	Homo sapiens	Inhibition	%	4.53
	8082505	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.01	CHEMBL4014	Homo sapiens	Inhibition	%	-2.01
	8082852	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.15	CHEMBL4014	Homo sapiens	Inhibition	%	3.15
	8083008	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	5.54	CHEMBL4014	Homo sapiens	Inhibition	%	5.54
	8083232	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	4.28	CHEMBL4014	Homo sapiens	Inhibition	%	4.28
	8083331	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	8.28	CHEMBL4014	Homo sapiens	Inhibition	%	8.28
	8083585	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.35	CHEMBL4014	Homo sapiens	Inhibition	%	1.35
	8083809	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	3.74	CHEMBL4014	Homo sapiens	Inhibition	%	3.74
	8083919	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.89	CHEMBL4014	Homo sapiens	Inhibition	%	2.89
	8084104	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.0	CHEMBL4014	Homo sapiens	Inhibition	%	3.0
	8084328	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	4.85	CHEMBL4014	Homo sapiens	Inhibition	%	4.85
	8084446	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.48	CHEMBL4014	Homo sapiens	Inhibition	%	0.48
	8084831	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.85	CHEMBL4014	Homo sapiens	Inhibition	%	9.85
	8084929	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.46	CHEMBL4014	Homo sapiens	Inhibition	%	2.46
	8085153	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.55	CHEMBL4014	Homo sapiens	Inhibition	%	3.55
	8085409	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	20.33	CHEMBL4014	Homo sapiens	Inhibition	%	20.33
	8085517	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.64	CHEMBL4014	Homo sapiens	Inhibition	%	7.64
	8085741	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.42	CHEMBL4014	Homo sapiens	Inhibition	%	3.42
	8085930	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	33.67	CHEMBL4014	Homo sapiens	Inhibition	%	33.67
	8086045	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.06	CHEMBL4014	Homo sapiens	Inhibition	%	1.06
	8086269	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	8.48	CHEMBL4014	Homo sapiens	Inhibition	%	8.48
	8086431	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-0.95	CHEMBL4014	Homo sapiens	Inhibition	%	-0.95
	8086754	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.85	CHEMBL4014	Homo sapiens	Inhibition	%	2.85
	8086965	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	7.46	CHEMBL4014	Homo sapiens	Inhibition	%	7.46
	8087347	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.38	CHEMBL4014	Homo sapiens	Inhibition	%	0.38
	8087461	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	73.93	CHEMBL4014	Homo sapiens	Inhibition	%	73.93
	8087823	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.38	CHEMBL4014	Homo sapiens	Inhibition	%	5.38
	8087965	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.81	CHEMBL4014	Homo sapiens	Inhibition	%	1.81
	8088189	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.42	CHEMBL4014	Homo sapiens	Inhibition	%	4.42
	8088337	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.05	CHEMBL4014	Homo sapiens	Inhibition	%	2.05
	8088689	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.24	CHEMBL4014	Homo sapiens	Inhibition	%	3.24
	8088782	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.04	CHEMBL4014	Homo sapiens	Inhibition	%	4.04
	8089006	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.0	CHEMBL4014	Homo sapiens	Inhibition	%	3.0
	8089134	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	4.89	CHEMBL4014	Homo sapiens	Inhibition	%	4.89
	8089506	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	3.09	CHEMBL4014	Homo sapiens	Inhibition	%	3.09
	8089626	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	19.22	CHEMBL4014	Homo sapiens	Inhibition	%	19.22
	8089850	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.89	CHEMBL4014	Homo sapiens	Inhibition	%	4.89
	8090030	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.62	CHEMBL4014	Homo sapiens	Inhibition	%	3.62
	8090195	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.03	CHEMBL4014	Homo sapiens	Inhibition	%	-1.03
	8090586	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.85	CHEMBL4014	Homo sapiens	Inhibition	%	2.85
	8090725	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	8.28	CHEMBL4014	Homo sapiens	Inhibition	%	8.28
	8090949	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	20.18	CHEMBL4014	Homo sapiens	Inhibition	%	20.18
	8091154	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.73	CHEMBL4014	Homo sapiens	Inhibition	%	2.73
	8091291	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	35.68	CHEMBL4014	Homo sapiens	Inhibition	%	35.68
	8091670	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.75	CHEMBL4014	Homo sapiens	Inhibition	%	3.75
	8091786	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.08	CHEMBL4014	Homo sapiens	Inhibition	%	7.08
	8092010	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	11.15	CHEMBL4014	Homo sapiens	Inhibition	%	11.15
	8092147	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-2.93	CHEMBL4014	Homo sapiens	Inhibition	%	-2.93
	8092522	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.95	CHEMBL4014	Homo sapiens	Inhibition	%	2.95
	8092670	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	7.11	CHEMBL4014	Homo sapiens	Inhibition	%	7.11
	8093023	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	11.43	CHEMBL4014	Homo sapiens	Inhibition	%	11.43
	8093335	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.63	CHEMBL4014	Homo sapiens	Inhibition	%	3.63
	8093475	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	12.32	CHEMBL4014	Homo sapiens	Inhibition	%	12.32
	8093838	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	14.0	CHEMBL4014	Homo sapiens	Inhibition	%	14.0
	8094182	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	24.51	CHEMBL4014	Homo sapiens	Inhibition	%	24.51
	8094362	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.77	CHEMBL4014	Homo sapiens	Inhibition	%	2.77
	8094537	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.11	CHEMBL4014	Homo sapiens	Inhibition	%	-1.11
	8094761	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-0.12	CHEMBL4014	Homo sapiens	Inhibition	%	-0.12
	8094917	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.35	CHEMBL4014	Homo sapiens	Inhibition	%	4.35
	8095281	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	71.91	CHEMBL4014	Homo sapiens	Inhibition	%	71.91
	8095484	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.87	CHEMBL4014	Homo sapiens	Inhibition	%	4.87
	8095625	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	10.01	CHEMBL4014	Homo sapiens	Inhibition	%	10.01
	8095849	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	13.0	CHEMBL4014	Homo sapiens	Inhibition	%	13.0
	8095997	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.85	CHEMBL4014	Homo sapiens	Inhibition	%	0.85
	8096338	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.73	CHEMBL4014	Homo sapiens	Inhibition	%	5.73
	8096477	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.16	CHEMBL4014	Homo sapiens	Inhibition	%	-3.16
	8096701	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.82	CHEMBL4014	Homo sapiens	Inhibition	%	1.82
	8096857	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.38	CHEMBL4014	Homo sapiens	Inhibition	%	6.38
	8097004	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.27	CHEMBL4014	Homo sapiens	Inhibition	%	1.27
	8097228	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	5.37	CHEMBL4014	Homo sapiens	Inhibition	%	5.37
	8097315	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.05	CHEMBL4014	Homo sapiens	Inhibition	%	-0.05
	8097535	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.2	CHEMBL4014	Homo sapiens	Inhibition	%	7.2
	8097685	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.61	CHEMBL4014	Homo sapiens	Inhibition	%	5.61
	8097909	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.83	CHEMBL4014	Homo sapiens	Inhibition	%	1.83
	8098042	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.6	CHEMBL4014	Homo sapiens	Inhibition	%	-0.6
	8098386	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.24	CHEMBL4014	Homo sapiens	Inhibition	%	-0.24
	8098566	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	8.69	CHEMBL4014	Homo sapiens	Inhibition	%	8.69
	8098975	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.78	CHEMBL4014	Homo sapiens	Inhibition	%	2.78
	8099119	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.06	CHEMBL4014	Homo sapiens	Inhibition	%	3.06
	8099485	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	6.5	CHEMBL4014	Homo sapiens	Inhibition	%	6.5
	8099679	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.94	CHEMBL4014	Homo sapiens	Inhibition	%	0.94
	8100050	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	64.21	CHEMBL4014	Homo sapiens	Inhibition	%	64.21
	8100196	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.75	CHEMBL4014	Homo sapiens	Inhibition	%	4.75
	8100536	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	8.03	CHEMBL4014	Homo sapiens	Inhibition	%	8.03
	8100900	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.39	CHEMBL4014	Homo sapiens	Inhibition	%	3.39
	8101060	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.92	CHEMBL4014	Homo sapiens	Inhibition	%	3.92
	8101426	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	9.54	CHEMBL4014	Homo sapiens	Inhibition	%	9.54
	8101611	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.99	CHEMBL4014	Homo sapiens	Inhibition	%	-1.99
	8101864	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	41.83	CHEMBL4014	Homo sapiens	Inhibition	%	41.83
	8102243	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	69.13	CHEMBL4014	Homo sapiens	Inhibition	%	69.13
	8102374	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.96	CHEMBL4014	Homo sapiens	Inhibition	%	3.96
	8102598	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	6.09	CHEMBL4014	Homo sapiens	Inhibition	%	6.09
	8102718	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.86	CHEMBL4014	Homo sapiens	Inhibition	%	0.86
	8102896	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.41	CHEMBL4014	Homo sapiens	Inhibition	%	2.41
	8103120	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	4.34	CHEMBL4014	Homo sapiens	Inhibition	%	4.34
	8103316	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.63	CHEMBL4014	Homo sapiens	Inhibition	%	2.63
	8103454	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.08	CHEMBL4014	Homo sapiens	Inhibition	%	4.08
	8103678	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	11.46	CHEMBL4014	Homo sapiens	Inhibition	%	11.46
	8103828	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	10.39	CHEMBL4014	Homo sapiens	Inhibition	%	10.39
	8104013	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.29	CHEMBL4014	Homo sapiens	Inhibition	%	5.29
	8104237	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	12.27	CHEMBL4014	Homo sapiens	Inhibition	%	12.27
	8104385	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	40.52	CHEMBL4014	Homo sapiens	Inhibition	%	40.52
	8104531	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.55	CHEMBL4014	Homo sapiens	Inhibition	%	-0.55
	8104755	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	9.88	CHEMBL4014	Homo sapiens	Inhibition	%	9.88
	8104869	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.9	CHEMBL4014	Homo sapiens	Inhibition	%	1.9
	8105233	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.95	CHEMBL4014	Homo sapiens	Inhibition	%	3.95
	8105399	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.08	CHEMBL4014	Homo sapiens	Inhibition	%	4.08
	8105623	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.57	CHEMBL4014	Homo sapiens	Inhibition	%	-1.57
	8105761	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	52.07	CHEMBL4014	Homo sapiens	Inhibition	%	52.07
	8106041	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.39	CHEMBL4014	Homo sapiens	Inhibition	%	2.39
	8106206	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	78.58	CHEMBL4014	Homo sapiens	Inhibition	%	78.58
	8106430	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.2	CHEMBL4014	Homo sapiens	Inhibition	%	2.2
	8106586	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	88.62	CHEMBL4014	Homo sapiens	Inhibition	%	88.62
	8106939	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	36.61	CHEMBL4014	Homo sapiens	Inhibition	%	36.61
	8107060	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.39	CHEMBL4014	Homo sapiens	Inhibition	%	0.39
	8107456	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.86	CHEMBL4014	Homo sapiens	Inhibition	%	2.86
	8107657	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.84	CHEMBL4014	Homo sapiens	Inhibition	%	3.84
	8108016	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	51.88	CHEMBL4014	Homo sapiens	Inhibition	%	51.88
	8108174	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.79	CHEMBL4014	Homo sapiens	Inhibition	%	5.79
	8108573	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	28.78	CHEMBL4014	Homo sapiens	Inhibition	%	28.78
	8108720	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.53	CHEMBL4014	Homo sapiens	Inhibition	%	8.53
	8109086	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.62	CHEMBL4014	Homo sapiens	Inhibition	%	2.62
	8109200	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.94	CHEMBL4014	Homo sapiens	Inhibition	%	6.94
	8109424	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.44	CHEMBL4014	Homo sapiens	Inhibition	%	2.44
	8109554	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.16	CHEMBL4014	Homo sapiens	Inhibition	%	-0.16
	8109949	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.18	CHEMBL4014	Homo sapiens	Inhibition	%	2.18
	8110081	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.68	CHEMBL4014	Homo sapiens	Inhibition	%	5.68
	8110360	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.22	CHEMBL4014	Homo sapiens	Inhibition	%	5.22
	8110750	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	6.34	CHEMBL4014	Homo sapiens	Inhibition	%	6.34
	8110908	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.47	CHEMBL4014	Homo sapiens	Inhibition	%	-2.47
	8111255	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	14.82	CHEMBL4014	Homo sapiens	Inhibition	%	14.82
	8111382	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	6.44	CHEMBL4014	Homo sapiens	Inhibition	%	6.44
	8111606	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.42	CHEMBL4014	Homo sapiens	Inhibition	%	1.42
	8111772	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.58	CHEMBL4014	Homo sapiens	Inhibition	%	4.58
	8111977	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.13	CHEMBL4014	Homo sapiens	Inhibition	%	3.13
	8112338	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.17	CHEMBL4014	Homo sapiens	Inhibition	%	-0.17
	8112506	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	13.25	CHEMBL4014	Homo sapiens	Inhibition	%	13.25
	8112730	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	35.44	CHEMBL4014	Homo sapiens	Inhibition	%	35.44
	8112902	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.41	CHEMBL4014	Homo sapiens	Inhibition	%	1.41
	8113054	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	12.42	CHEMBL4014	Homo sapiens	Inhibition	%	12.42
	8113278	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.91	CHEMBL4014	Homo sapiens	Inhibition	%	1.91
	8113414	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	6.65	CHEMBL4014	Homo sapiens	Inhibition	%	6.65
	8113762	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.31	CHEMBL4014	Homo sapiens	Inhibition	%	4.31
	8113878	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.0	CHEMBL4014	Homo sapiens	Inhibition	%	-1.0
	8114278	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.21	CHEMBL4014	Homo sapiens	Inhibition	%	4.21
	8114410	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	29.43	CHEMBL4014	Homo sapiens	Inhibition	%	29.43
	8114634	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.36	CHEMBL4014	Homo sapiens	Inhibition	%	4.36
	8114686	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.04	CHEMBL4014	Homo sapiens	Inhibition	%	4.04
	8114910	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	8.56	CHEMBL4014	Homo sapiens	Inhibition	%	8.56
	8115076	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	25.19	CHEMBL4014	Homo sapiens	Inhibition	%	25.19
	8115241	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.76	CHEMBL4014	Homo sapiens	Inhibition	%	-0.76
	8115465	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.55	CHEMBL4014	Homo sapiens	Inhibition	%	0.55
	8115585	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	44.77	CHEMBL4014	Homo sapiens	Inhibition	%	44.77
	8115942	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.28	CHEMBL4014	Homo sapiens	Inhibition	%	2.28
	8116101	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.16	CHEMBL4014	Homo sapiens	Inhibition	%	-1.16
	8116304	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	18.01	CHEMBL4014	Homo sapiens	Inhibition	%	18.01
	8116528	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.02	CHEMBL4014	Homo sapiens	Inhibition	%	2.02
	8116662	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	5.82	CHEMBL4014	Homo sapiens	Inhibition	%	5.82
	8117058	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	78.44	CHEMBL4014	Homo sapiens	Inhibition	%	78.44
	8117229	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.46	CHEMBL4014	Homo sapiens	Inhibition	%	3.46
	8117611	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.33	CHEMBL4014	Homo sapiens	Inhibition	%	4.33
	8117741	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.92	CHEMBL4014	Homo sapiens	Inhibition	%	0.92
	8118103	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-1.34	CHEMBL4014	Homo sapiens	Inhibition	%	-1.34
	8118219	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.4	CHEMBL4014	Homo sapiens	Inhibition	%	-1.4
	8118443	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.13	CHEMBL4014	Homo sapiens	Inhibition	%	2.13
	8118615	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	8.35	CHEMBL4014	Homo sapiens	Inhibition	%	8.35
	8118975	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	7.39	CHEMBL4014	Homo sapiens	Inhibition	%	7.39
	8119246	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.11	CHEMBL4014	Homo sapiens	Inhibition	%	1.11
	8119405	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	64.18	CHEMBL4014	Homo sapiens	Inhibition	%	64.18
	8119796	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.74	CHEMBL4014	Homo sapiens	Inhibition	%	3.74
	8119915	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	4.58	CHEMBL4014	Homo sapiens	Inhibition	%	4.58
	8120278	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.56	CHEMBL4014	Homo sapiens	Inhibition	%	2.56
	8120438	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.31	CHEMBL4014	Homo sapiens	Inhibition	%	3.31
	8120662	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.58	CHEMBL4014	Homo sapiens	Inhibition	%	-0.58
	8120863	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.67	CHEMBL4014	Homo sapiens	Inhibition	%	3.67
	8120991	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.65	CHEMBL4014	Homo sapiens	Inhibition	%	3.65
	8121215	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	25.69	CHEMBL4014	Homo sapiens	Inhibition	%	25.69
	8121387	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.08	CHEMBL4014	Homo sapiens	Inhibition	%	-0.08
	8121554	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.11	CHEMBL4014	Homo sapiens	Inhibition	%	2.11
	8121941	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.44	CHEMBL4014	Homo sapiens	Inhibition	%	4.44
	8122062	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	5.67	CHEMBL4014	Homo sapiens	Inhibition	%	5.67
	8122286	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	23.93	CHEMBL4014	Homo sapiens	Inhibition	%	23.93
	8122424	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.3	CHEMBL4014	Homo sapiens	Inhibition	%	0.3
	8122768	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.9	CHEMBL4014	Homo sapiens	Inhibition	%	3.9
	8122935	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.61	CHEMBL4014	Homo sapiens	Inhibition	%	5.61
	8123301	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.15	CHEMBL4014	Homo sapiens	Inhibition	%	2.15
	8123579	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.02	CHEMBL4014	Homo sapiens	Inhibition	%	-0.02
	8123729	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	11.56	CHEMBL4014	Homo sapiens	Inhibition	%	11.56
	8123953	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	71.51	CHEMBL4014	Homo sapiens	Inhibition	%	71.51
	8124120	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	12.69	CHEMBL4014	Homo sapiens	Inhibition	%	12.69
	8124239	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	9.66	CHEMBL4014	Homo sapiens	Inhibition	%	9.66
	8124463	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	6.41	CHEMBL4014	Homo sapiens	Inhibition	%	6.41
	8124602	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	5.0	CHEMBL4014	Homo sapiens	Inhibition	%	5.0
	8124991	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.25	CHEMBL4014	Homo sapiens	Inhibition	%	2.25
	8125192	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.69	CHEMBL4014	Homo sapiens	Inhibition	%	2.69
	8125546	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.77	CHEMBL4014	Homo sapiens	Inhibition	%	0.77
	8125714	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.38	CHEMBL4014	Homo sapiens	Inhibition	%	-0.38
	8125878	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.55	CHEMBL4014	Homo sapiens	Inhibition	%	3.55
	8126102	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.05	CHEMBL4014	Homo sapiens	Inhibition	%	1.05
	8126266	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.23	CHEMBL4014	Homo sapiens	Inhibition	%	7.23
	8126605	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	56.39	CHEMBL4014	Homo sapiens	Inhibition	%	56.39
	8126741	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	5.92	CHEMBL4014	Homo sapiens	Inhibition	%	5.92
	8127087	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.96	CHEMBL4014	Homo sapiens	Inhibition	%	2.96
	8127254	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	11.76	CHEMBL4014	Homo sapiens	Inhibition	%	11.76
	8127478	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	32.8	CHEMBL4014	Homo sapiens	Inhibition	%	32.8
	8127620	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	13.24	CHEMBL4014	Homo sapiens	Inhibition	%	13.24
	8127908	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.57	CHEMBL4014	Homo sapiens	Inhibition	%	2.57
	8128284	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.85	CHEMBL4014	Homo sapiens	Inhibition	%	4.85
	8128451	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	59.45	CHEMBL4014	Homo sapiens	Inhibition	%	59.45
	8128794	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	44.2	CHEMBL4014	Homo sapiens	Inhibition	%	44.2
	8128931	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.92	CHEMBL4014	Homo sapiens	Inhibition	%	2.92
	8129155	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.78	CHEMBL4014	Homo sapiens	Inhibition	%	3.78
	8129326	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.43	CHEMBL4014	Homo sapiens	Inhibition	%	2.43
	8129515	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.01	CHEMBL4014	Homo sapiens	Inhibition	%	5.01
	8129878	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.61	CHEMBL4014	Homo sapiens	Inhibition	%	3.61
	8130039	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.3	CHEMBL4014	Homo sapiens	Inhibition	%	0.3
	8130435	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.43	CHEMBL4014	Homo sapiens	Inhibition	%	1.43
	8130595	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.47	CHEMBL4014	Homo sapiens	Inhibition	%	1.47
	8130935	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.57	CHEMBL4014	Homo sapiens	Inhibition	%	3.57
	8131074	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	21.77	CHEMBL4014	Homo sapiens	Inhibition	%	21.77
	8131298	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.57	CHEMBL4014	Homo sapiens	Inhibition	%	2.57
	8131418	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.58	CHEMBL4014	Homo sapiens	Inhibition	%	3.58
	8131809	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	74.59	CHEMBL4014	Homo sapiens	Inhibition	%	74.59
	8131950	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	33.61	CHEMBL4014	Homo sapiens	Inhibition	%	33.61
	8132236	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.57	CHEMBL4014	Homo sapiens	Inhibition	%	0.57
	8132607	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	12.0	CHEMBL4014	Homo sapiens	Inhibition	%	12.0
	8132775	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.13	CHEMBL4014	Homo sapiens	Inhibition	%	4.13
	8133120	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.17	CHEMBL4014	Homo sapiens	Inhibition	%	3.17
	8133482	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.37	CHEMBL4014	Homo sapiens	Inhibition	%	3.37
	8133654	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	18.57	CHEMBL4014	Homo sapiens	Inhibition	%	18.57
	8133834	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	21.93	CHEMBL4014	Homo sapiens	Inhibition	%	21.93
	8134058	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	56.54	CHEMBL4014	Homo sapiens	Inhibition	%	56.54
	8134206	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.1	CHEMBL4014	Homo sapiens	Inhibition	%	0.1
	8134366	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.29	CHEMBL4014	Homo sapiens	Inhibition	%	3.29
	8134590	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.28	CHEMBL4014	Homo sapiens	Inhibition	%	2.28
	8134774	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.2	CHEMBL4014	Homo sapiens	Inhibition	%	0.2
	8134934	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	22.19	CHEMBL4014	Homo sapiens	Inhibition	%	22.19
	8135158	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.89	CHEMBL4014	Homo sapiens	Inhibition	%	5.89
	8135273	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	5.04	CHEMBL4014	Homo sapiens	Inhibition	%	5.04
	8135638	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.54	CHEMBL4014	Homo sapiens	Inhibition	%	4.54
	8135759	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.62	CHEMBL4014	Homo sapiens	Inhibition	%	-1.62
	8135983	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-2.12	CHEMBL4014	Homo sapiens	Inhibition	%	-2.12
	8136151	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.78	CHEMBL4014	Homo sapiens	Inhibition	%	2.78
	8136295	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	64.69	CHEMBL4014	Homo sapiens	Inhibition	%	64.69
	8136519	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.06	CHEMBL4014	Homo sapiens	Inhibition	%	5.06
	8136585	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.32	CHEMBL4014	Homo sapiens	Inhibition	%	-2.32
	8136809	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.83	CHEMBL4014	Homo sapiens	Inhibition	%	-3.83
	8136944	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.19	CHEMBL4014	Homo sapiens	Inhibition	%	2.19
	8137107	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	21.1	CHEMBL4014	Homo sapiens	Inhibition	%	21.1
	8137331	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	11.62	CHEMBL4014	Homo sapiens	Inhibition	%	11.62
	8137451	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.59	CHEMBL4014	Homo sapiens	Inhibition	%	7.59
	8137823	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.96	CHEMBL4014	Homo sapiens	Inhibition	%	3.96
	8137989	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.22	CHEMBL4014	Homo sapiens	Inhibition	%	-0.22
	8138392	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.49	CHEMBL4014	Homo sapiens	Inhibition	%	1.49
	8138540	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	5.3	CHEMBL4014	Homo sapiens	Inhibition	%	5.3
	8138922	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.36	CHEMBL4014	Homo sapiens	Inhibition	%	2.36
	8139107	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	8.69	CHEMBL4014	Homo sapiens	Inhibition	%	8.69
	8139490	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	20.18	CHEMBL4014	Homo sapiens	Inhibition	%	20.18
	8139604	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.59	CHEMBL4014	Homo sapiens	Inhibition	%	4.59
	8139828	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.76	CHEMBL4014	Homo sapiens	Inhibition	%	4.76
	8139969	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.01	CHEMBL4014	Homo sapiens	Inhibition	%	1.01
	8140316	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.39	CHEMBL4014	Homo sapiens	Inhibition	%	3.39
	8140475	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	15.16	CHEMBL4014	Homo sapiens	Inhibition	%	15.16
	8140842	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	9.0	CHEMBL4014	Homo sapiens	Inhibition	%	9.0
	8141144	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.02	CHEMBL4014	Homo sapiens	Inhibition	%	2.02
	8141274	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.97	CHEMBL4014	Homo sapiens	Inhibition	%	3.97
	8141658	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	61.86	CHEMBL4014	Homo sapiens	Inhibition	%	61.86
	8141777	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	7.09	CHEMBL4014	Homo sapiens	Inhibition	%	7.09
	8142001	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	51.33	CHEMBL4014	Homo sapiens	Inhibition	%	51.33
	8142162	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	5.47	CHEMBL4014	Homo sapiens	Inhibition	%	5.47
	8142330	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.82	CHEMBL4014	Homo sapiens	Inhibition	%	1.82
	8142554	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.15	CHEMBL4014	Homo sapiens	Inhibition	%	0.15
	8142730	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.56	CHEMBL4014	Homo sapiens	Inhibition	%	4.56
	8142879	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.09	CHEMBL4014	Homo sapiens	Inhibition	%	-2.09
	8143103	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.41	CHEMBL4014	Homo sapiens	Inhibition	%	-0.41
	8143258	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.43	CHEMBL4014	Homo sapiens	Inhibition	%	3.43
	8143445	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.07	CHEMBL4014	Homo sapiens	Inhibition	%	4.07
	8143669	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	6.48	CHEMBL4014	Homo sapiens	Inhibition	%	6.48
	8143828	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-9.35	CHEMBL4014	Homo sapiens	Inhibition	%	-9.35
	8144166	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.83	CHEMBL4014	Homo sapiens	Inhibition	%	0.83
	8144305	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.14	CHEMBL4014	Homo sapiens	Inhibition	%	7.14
	8144659	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.05	CHEMBL4014	Homo sapiens	Inhibition	%	5.05
	8144812	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.17	CHEMBL4014	Homo sapiens	Inhibition	%	2.17
	8145036	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.71	CHEMBL4014	Homo sapiens	Inhibition	%	3.71
	8145173	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.64	CHEMBL4014	Homo sapiens	Inhibition	%	4.64
	8145486	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	5.11	CHEMBL4014	Homo sapiens	Inhibition	%	5.11
	8145610	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.39	CHEMBL4014	Homo sapiens	Inhibition	%	4.39
	8145834	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.13	CHEMBL4014	Homo sapiens	Inhibition	%	6.13
	8145995	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	25.05	CHEMBL4014	Homo sapiens	Inhibition	%	25.05
	8146339	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	11.83	CHEMBL4014	Homo sapiens	Inhibition	%	11.83
	8146499	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	33.17	CHEMBL4014	Homo sapiens	Inhibition	%	33.17
	8146890	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	3.87	CHEMBL4014	Homo sapiens	Inhibition	%	3.87
	8147059	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.31	CHEMBL4014	Homo sapiens	Inhibition	%	2.31
	8147425	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.3	CHEMBL4014	Homo sapiens	Inhibition	%	3.3
	8147578	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.12	CHEMBL4014	Homo sapiens	Inhibition	%	4.12
	8147989	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.66	CHEMBL4014	Homo sapiens	Inhibition	%	5.66
	8148147	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	33.67	CHEMBL4014	Homo sapiens	Inhibition	%	33.67
	8148485	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.36	CHEMBL4014	Homo sapiens	Inhibition	%	4.36
	8148624	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.72	CHEMBL4014	Homo sapiens	Inhibition	%	1.72
	8148848	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.61	CHEMBL4014	Homo sapiens	Inhibition	%	3.61
	8148986	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.35	CHEMBL4014	Homo sapiens	Inhibition	%	2.35
	8149369	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.62	CHEMBL4014	Homo sapiens	Inhibition	%	-2.62
	8149503	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	8.2	CHEMBL4014	Homo sapiens	Inhibition	%	8.2
	8149825	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	9.35	CHEMBL4014	Homo sapiens	Inhibition	%	9.35
	8150174	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	35.63	CHEMBL4014	Homo sapiens	Inhibition	%	35.63
	8150334	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	55.1	CHEMBL4014	Homo sapiens	Inhibition	%	55.1
	8150678	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	58.91	CHEMBL4014	Homo sapiens	Inhibition	%	58.91
	8150843	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	5.49	CHEMBL4014	Homo sapiens	Inhibition	%	5.49
	8151067	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	8.21	CHEMBL4014	Homo sapiens	Inhibition	%	8.21
	8151230	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.18	CHEMBL4014	Homo sapiens	Inhibition	%	-1.18
	8151407	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.83	CHEMBL4014	Homo sapiens	Inhibition	%	4.83
	8151769	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.79	CHEMBL4014	Homo sapiens	Inhibition	%	3.79
	8151923	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.28	CHEMBL4014	Homo sapiens	Inhibition	%	2.28
	8152147	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	6.55	CHEMBL4014	Homo sapiens	Inhibition	%	6.55
	8152335	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	15.39	CHEMBL4014	Homo sapiens	Inhibition	%	15.39
	8152493	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.2	CHEMBL4014	Homo sapiens	Inhibition	%	5.2
	8152717	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	22.67	CHEMBL4014	Homo sapiens	Inhibition	%	22.67
	8152831	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	41.96	CHEMBL4014	Homo sapiens	Inhibition	%	41.96
	8153194	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.03	CHEMBL4014	Homo sapiens	Inhibition	%	3.03
	8153331	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.64	CHEMBL4014	Homo sapiens	Inhibition	%	3.64
	8153712	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.72	CHEMBL4014	Homo sapiens	Inhibition	%	-1.72
	8153845	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.36	CHEMBL4014	Homo sapiens	Inhibition	%	2.36
	8154069	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.11	CHEMBL4014	Homo sapiens	Inhibition	%	4.11
	8154166	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	64.3	CHEMBL4014	Homo sapiens	Inhibition	%	64.3
	8154516	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	66.44	CHEMBL4014	Homo sapiens	Inhibition	%	66.44
	8154675	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.79	CHEMBL4014	Homo sapiens	Inhibition	%	2.79
	8154899	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.76	CHEMBL4014	Homo sapiens	Inhibition	%	4.76
	8155019	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	5.35	CHEMBL4014	Homo sapiens	Inhibition	%	5.35
	8155419	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.16	CHEMBL4014	Homo sapiens	Inhibition	%	2.16
	8155580	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.73	CHEMBL4014	Homo sapiens	Inhibition	%	0.73
	8155758	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.35	CHEMBL4014	Homo sapiens	Inhibition	%	2.35
	8155982	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.86	CHEMBL4014	Homo sapiens	Inhibition	%	5.86
	8156120	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.04	CHEMBL4014	Homo sapiens	Inhibition	%	2.04
	8156332	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.33	CHEMBL4014	Homo sapiens	Inhibition	%	3.33
	8156556	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.64	CHEMBL4014	Homo sapiens	Inhibition	%	3.64
	8156706	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	60.8	CHEMBL4014	Homo sapiens	Inhibition	%	60.8
	8157073	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	42.02	CHEMBL4014	Homo sapiens	Inhibition	%	42.02
	8157193	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	7.56	CHEMBL4014	Homo sapiens	Inhibition	%	7.56
	8157558	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.85	CHEMBL4014	Homo sapiens	Inhibition	%	3.85
	8157688	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	65.89	CHEMBL4014	Homo sapiens	Inhibition	%	65.89
	8157912	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	7.45	CHEMBL4014	Homo sapiens	Inhibition	%	7.45
	8158073	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	5.98	CHEMBL4014	Homo sapiens	Inhibition	%	5.98
	8158323	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	11.67	CHEMBL4014	Homo sapiens	Inhibition	%	11.67
	8158705	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	7.46	CHEMBL4014	Homo sapiens	Inhibition	%	7.46
	8158874	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.87	CHEMBL4014	Homo sapiens	Inhibition	%	3.87
	8159233	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.82	CHEMBL4014	Homo sapiens	Inhibition	%	0.82
	8159353	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.51	CHEMBL4014	Homo sapiens	Inhibition	%	3.51
	8159577	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.22	CHEMBL4014	Homo sapiens	Inhibition	%	-2.22
	8159708	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.81	CHEMBL4014	Homo sapiens	Inhibition	%	6.81
	8160073	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.67	CHEMBL4014	Homo sapiens	Inhibition	%	4.67
	8160210	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.84	CHEMBL4014	Homo sapiens	Inhibition	%	5.84
	8160584	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.37	CHEMBL4014	Homo sapiens	Inhibition	%	0.37
	8160878	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.5	CHEMBL4014	Homo sapiens	Inhibition	%	2.5
	8161028	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	6.09	CHEMBL4014	Homo sapiens	Inhibition	%	6.09
	8161395	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.27	CHEMBL4014	Homo sapiens	Inhibition	%	7.27
	8161520	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	7.08	CHEMBL4014	Homo sapiens	Inhibition	%	7.08
	8161744	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.43	CHEMBL4014	Homo sapiens	Inhibition	%	4.43
	8161882	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	13.1	CHEMBL4014	Homo sapiens	Inhibition	%	13.1
	8162236	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	10.1	CHEMBL4014	Homo sapiens	Inhibition	%	10.1
	8162396	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.15	CHEMBL4014	Homo sapiens	Inhibition	%	-0.15
	8162649	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.33	CHEMBL4014	Homo sapiens	Inhibition	%	5.33
	8163021	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.56	CHEMBL4014	Homo sapiens	Inhibition	%	5.56
	8163190	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	18.98	CHEMBL4014	Homo sapiens	Inhibition	%	18.98
	8163414	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.88	CHEMBL4014	Homo sapiens	Inhibition	%	3.88
	8163548	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.68	CHEMBL4014	Homo sapiens	Inhibition	%	0.68
	8163895	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.07	CHEMBL4014	Homo sapiens	Inhibition	%	2.07
	8164029	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.38	CHEMBL4014	Homo sapiens	Inhibition	%	2.38
	8164393	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-1.89	CHEMBL4014	Homo sapiens	Inhibition	%	-1.89
	8164548	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.84	CHEMBL4014	Homo sapiens	Inhibition	%	5.84
	8164772	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	11.91	CHEMBL4014	Homo sapiens	Inhibition	%	11.91
	8164916	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	30.34	CHEMBL4014	Homo sapiens	Inhibition	%	30.34
	8165210	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.06	CHEMBL4014	Homo sapiens	Inhibition	%	2.06
	8165351	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	36.03	CHEMBL4014	Homo sapiens	Inhibition	%	36.03
	8165575	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.61	CHEMBL4014	Homo sapiens	Inhibition	%	3.61
	8165718	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	43.89	CHEMBL4014	Homo sapiens	Inhibition	%	43.89
	8166068	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.33	CHEMBL4014	Homo sapiens	Inhibition	%	1.33
	8166206	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.38	CHEMBL4014	Homo sapiens	Inhibition	%	3.38
	8166560	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	13.17	CHEMBL4014	Homo sapiens	Inhibition	%	13.17
	8166885	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	69.87	CHEMBL4014	Homo sapiens	Inhibition	%	69.87
	8166973	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	7.29	CHEMBL4014	Homo sapiens	Inhibition	%	7.29
	8167197	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.56	CHEMBL4014	Homo sapiens	Inhibition	%	4.56
	8167338	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	31.4	CHEMBL4014	Homo sapiens	Inhibition	%	31.4
	8167726	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	9.55	CHEMBL4014	Homo sapiens	Inhibition	%	9.55
	8167859	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.97	CHEMBL4014	Homo sapiens	Inhibition	%	3.97
	8168207	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.2	CHEMBL4014	Homo sapiens	Inhibition	%	2.2
	8168348	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	3.99	CHEMBL4014	Homo sapiens	Inhibition	%	3.99
	8168572	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.85	CHEMBL4014	Homo sapiens	Inhibition	%	4.85
	8168708	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.01	CHEMBL4014	Homo sapiens	Inhibition	%	1.01
	8169096	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	44.32	CHEMBL4014	Homo sapiens	Inhibition	%	44.32
	8169238	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.46	CHEMBL4014	Homo sapiens	Inhibition	%	2.46
	8169542	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.83	CHEMBL4014	Homo sapiens	Inhibition	%	5.83
	8169900	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	10.19	CHEMBL4014	Homo sapiens	Inhibition	%	10.19
	8170045	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	6.22	CHEMBL4014	Homo sapiens	Inhibition	%	6.22
	8170394	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.22	CHEMBL4014	Homo sapiens	Inhibition	%	3.22
	8170534	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	9.78	CHEMBL4014	Homo sapiens	Inhibition	%	9.78
	8170758	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.08	CHEMBL4014	Homo sapiens	Inhibition	%	-1.08
	8170893	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	50.84	CHEMBL4014	Homo sapiens	Inhibition	%	50.84
	8171090	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	15.44	CHEMBL4014	Homo sapiens	Inhibition	%	15.44
	8171314	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	18.37	CHEMBL4014	Homo sapiens	Inhibition	%	18.37
	8171531	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	7.99	CHEMBL4014	Homo sapiens	Inhibition	%	7.99
	8171672	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.86	CHEMBL4014	Homo sapiens	Inhibition	%	2.86
	8172049	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.52	CHEMBL4014	Homo sapiens	Inhibition	%	3.52
	8172181	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.07	CHEMBL4014	Homo sapiens	Inhibition	%	6.07
	8172405	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	7.75	CHEMBL4014	Homo sapiens	Inhibition	%	7.75
	8172533	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	19.73	CHEMBL4014	Homo sapiens	Inhibition	%	19.73
	8172899	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	10.14	CHEMBL4014	Homo sapiens	Inhibition	%	10.14
	8173035	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.16	CHEMBL4014	Homo sapiens	Inhibition	%	-1.16
	8173424	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	47.75	CHEMBL4014	Homo sapiens	Inhibition	%	47.75
	8173565	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.71	CHEMBL4014	Homo sapiens	Inhibition	%	4.71
	8173789	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.5	CHEMBL4014	Homo sapiens	Inhibition	%	3.5
	8173876	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.29	CHEMBL4014	Homo sapiens	Inhibition	%	4.29
	8174232	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	12.5	CHEMBL4014	Homo sapiens	Inhibition	%	12.5
	8174380	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	48.88	CHEMBL4014	Homo sapiens	Inhibition	%	48.88
	8174604	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.93	CHEMBL4014	Homo sapiens	Inhibition	%	3.93
	8174726	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	10.05	CHEMBL4014	Homo sapiens	Inhibition	%	10.05
	8175093	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.22	CHEMBL4014	Homo sapiens	Inhibition	%	-2.22
	8175229	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.44	CHEMBL4014	Homo sapiens	Inhibition	%	4.44
	8175453	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	10.62	CHEMBL4014	Homo sapiens	Inhibition	%	10.62
	8175485	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.58	CHEMBL4014	Homo sapiens	Inhibition	%	3.58
	8175709	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	7.69	CHEMBL4014	Homo sapiens	Inhibition	%	7.69
	8175872	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	30.19	CHEMBL4014	Homo sapiens	Inhibition	%	30.19
	8176025	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.17	CHEMBL4014	Homo sapiens	Inhibition	%	4.17
	8176249	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.87	CHEMBL4014	Homo sapiens	Inhibition	%	4.87
	8176398	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	52.44	CHEMBL4014	Homo sapiens	Inhibition	%	52.44
	8176754	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	19.37	CHEMBL4014	Homo sapiens	Inhibition	%	19.37
	8176884	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	5.73	CHEMBL4014	Homo sapiens	Inhibition	%	5.73
	8177108	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	56.36	CHEMBL4014	Homo sapiens	Inhibition	%	56.36
	8177250	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	19.93	CHEMBL4014	Homo sapiens	Inhibition	%	19.93
	8177388	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.08	CHEMBL4014	Homo sapiens	Inhibition	%	1.08
	8177612	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.1	CHEMBL4014	Homo sapiens	Inhibition	%	3.1
	8177776	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	82.83	CHEMBL4014	Homo sapiens	Inhibition	%	82.83
	8178140	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.72	CHEMBL4014	Homo sapiens	Inhibition	%	5.72
	8178228	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	9.57	CHEMBL4014	Homo sapiens	Inhibition	%	9.57
	8178452	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.49	CHEMBL4014	Homo sapiens	Inhibition	%	3.49
	8178579	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	57.43	CHEMBL4014	Homo sapiens	Inhibition	%	57.43
	8178952	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	5.95	CHEMBL4014	Homo sapiens	Inhibition	%	5.95
	8179075	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.5	CHEMBL4014	Homo sapiens	Inhibition	%	3.5
	8179299	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.21	CHEMBL4014	Homo sapiens	Inhibition	%	5.21
	8179443	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.79	CHEMBL4014	Homo sapiens	Inhibition	%	2.79
	8179804	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.3	CHEMBL4014	Homo sapiens	Inhibition	%	7.3
	8180061	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.96	CHEMBL4014	Homo sapiens	Inhibition	%	0.96
	8180215	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	74.4	CHEMBL4014	Homo sapiens	Inhibition	%	74.4
	8180595	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.75	CHEMBL4014	Homo sapiens	Inhibition	%	6.75
	8180743	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.83	CHEMBL4014	Homo sapiens	Inhibition	%	2.83
	8181100	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	80.76	CHEMBL4014	Homo sapiens	Inhibition	%	80.76
	8181455	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.23	CHEMBL4014	Homo sapiens	Inhibition	%	-0.23
	8181595	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	68.58	CHEMBL4014	Homo sapiens	Inhibition	%	68.58
	8181958	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	12.08	CHEMBL4014	Homo sapiens	Inhibition	%	12.08
	8182121	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.71	CHEMBL4014	Homo sapiens	Inhibition	%	6.71
	8182485	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.43	CHEMBL4014	Homo sapiens	Inhibition	%	3.43
	8182801	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	6.24	CHEMBL4014	Homo sapiens	Inhibition	%	6.24
	8182923	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	9.51	CHEMBL4014	Homo sapiens	Inhibition	%	9.51
	8183147	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	57.91	CHEMBL4014	Homo sapiens	Inhibition	%	57.91
	8183296	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	27.28	CHEMBL4014	Homo sapiens	Inhibition	%	27.28
	8183649	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.58	CHEMBL4014	Homo sapiens	Inhibition	%	5.58
	8183791	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	9.41	CHEMBL4014	Homo sapiens	Inhibition	%	9.41
	8184151	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.25	CHEMBL4014	Homo sapiens	Inhibition	%	5.25
	8184417	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.58	CHEMBL4014	Homo sapiens	Inhibition	%	2.58
	8184564	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.02	CHEMBL4014	Homo sapiens	Inhibition	%	3.02
	8184788	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	9.41	CHEMBL4014	Homo sapiens	Inhibition	%	9.41
	8184945	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	10.4	CHEMBL4014	Homo sapiens	Inhibition	%	10.4
	8185094	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.52	CHEMBL4014	Homo sapiens	Inhibition	%	4.52
	8185318	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.67	CHEMBL4014	Homo sapiens	Inhibition	%	-0.67
	8185449	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%		CHEMBL4014	Homo sapiens	Inhibition	%	
	8185804	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	10.07	CHEMBL4014	Homo sapiens	Inhibition	%	10.07
	8185943	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.15	CHEMBL4014	Homo sapiens	Inhibition	%	6.15
	8186167	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	31.17	CHEMBL4014	Homo sapiens	Inhibition	%	31.17
	8186308	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.7	CHEMBL4014	Homo sapiens	Inhibition	%	2.7
	8186472	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	20.15	CHEMBL4014	Homo sapiens	Inhibition	%	20.15
	8186696	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.76	CHEMBL4014	Homo sapiens	Inhibition	%	6.76
	8186835	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.03	CHEMBL4014	Homo sapiens	Inhibition	%	4.03
	8187157	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	12.22	CHEMBL4014	Homo sapiens	Inhibition	%	12.22
	8187505	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.05	CHEMBL4014	Homo sapiens	Inhibition	%	4.05
	8187653	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	72.59	CHEMBL4014	Homo sapiens	Inhibition	%	72.59
	8188006	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	9.47	CHEMBL4014	Homo sapiens	Inhibition	%	9.47
	8188149	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.17	CHEMBL4014	Homo sapiens	Inhibition	%	5.17
	8188373	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	11.62	CHEMBL4014	Homo sapiens	Inhibition	%	11.62
	8188508	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	45.44	CHEMBL4014	Homo sapiens	Inhibition	%	45.44
	8188782	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.53	CHEMBL4014	Homo sapiens	Inhibition	%	4.53
	8189154	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	16.73	CHEMBL4014	Homo sapiens	Inhibition	%	16.73
	8189310	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	56.14	CHEMBL4014	Homo sapiens	Inhibition	%	56.14
	8189683	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.87	CHEMBL4014	Homo sapiens	Inhibition	%	-0.87
	8189815	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.87	CHEMBL4014	Homo sapiens	Inhibition	%	5.87
	8190039	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	14.79	CHEMBL4014	Homo sapiens	Inhibition	%	14.79
	8190171	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.44	CHEMBL4014	Homo sapiens	Inhibition	%	3.44
	8190535	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.19	CHEMBL4014	Homo sapiens	Inhibition	%	6.19
	8190672	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	11.86	CHEMBL4014	Homo sapiens	Inhibition	%	11.86
	8191060	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	12.29	CHEMBL4014	Homo sapiens	Inhibition	%	12.29
	8191198	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.95	CHEMBL4014	Homo sapiens	Inhibition	%	5.95
	8191422	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	16.79	CHEMBL4014	Homo sapiens	Inhibition	%	16.79
	8191518	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	59.31	CHEMBL4014	Homo sapiens	Inhibition	%	59.31
	8191864	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	19.06	CHEMBL4014	Homo sapiens	Inhibition	%	19.06
	8192013	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.58	CHEMBL4014	Homo sapiens	Inhibition	%	5.58
	8192237	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	12.91	CHEMBL4014	Homo sapiens	Inhibition	%	12.91
	8192366	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.31	CHEMBL4014	Homo sapiens	Inhibition	%	4.31
	8192734	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.78	CHEMBL4014	Homo sapiens	Inhibition	%	6.78
	8192870	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	61.67	CHEMBL4014	Homo sapiens	Inhibition	%	61.67
	8193142	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	10.72	CHEMBL4014	Homo sapiens	Inhibition	%	10.72
	8193511	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	68.53	CHEMBL4014	Homo sapiens	Inhibition	%	68.53
	8193668	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.2	CHEMBL4014	Homo sapiens	Inhibition	%	4.2
	8193892	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	13.3	CHEMBL4014	Homo sapiens	Inhibition	%	13.3
	8194041	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.18	CHEMBL4014	Homo sapiens	Inhibition	%	0.18
	8194396	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	15.83	CHEMBL4014	Homo sapiens	Inhibition	%	15.83
	8194527	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	15.11	CHEMBL4014	Homo sapiens	Inhibition	%	15.11
	8194894	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	54.19	CHEMBL4014	Homo sapiens	Inhibition	%	54.19
	8195027	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.07	CHEMBL4014	Homo sapiens	Inhibition	%	3.07
	8195251	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.99	CHEMBL4014	Homo sapiens	Inhibition	%	2.99
	8195415	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	5.9	CHEMBL4014	Homo sapiens	Inhibition	%	5.9
	8195778	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.94	CHEMBL4014	Homo sapiens	Inhibition	%	5.94
	8195876	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.72	CHEMBL4014	Homo sapiens	Inhibition	%	3.72
	8196100	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	8.41	CHEMBL4014	Homo sapiens	Inhibition	%	8.41
	8196217	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.8	CHEMBL4014	Homo sapiens	Inhibition	%	2.8
	8196591	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.61	CHEMBL4014	Homo sapiens	Inhibition	%	4.61
	8196719	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.39	CHEMBL4014	Homo sapiens	Inhibition	%	4.39
	8197084	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	16.14	CHEMBL4014	Homo sapiens	Inhibition	%	16.14
	8197221	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	6.07	CHEMBL4014	Homo sapiens	Inhibition	%	6.07
	8197445	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	9.53	CHEMBL4014	Homo sapiens	Inhibition	%	9.53
	8197496	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.26	CHEMBL4014	Homo sapiens	Inhibition	%	1.26
	8197720	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.07	CHEMBL4014	Homo sapiens	Inhibition	%	5.07
	8197860	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.8	CHEMBL4014	Homo sapiens	Inhibition	%	1.8
	8198241	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.16	CHEMBL4014	Homo sapiens	Inhibition	%	0.16
	8198379	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	7.36	CHEMBL4014	Homo sapiens	Inhibition	%	7.36
	8198733	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	65.15	CHEMBL4014	Homo sapiens	Inhibition	%	65.15
	8198864	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.83	CHEMBL4014	Homo sapiens	Inhibition	%	4.83
	8199088	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.28	CHEMBL4014	Homo sapiens	Inhibition	%	8.28
	8199236	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.28	CHEMBL4014	Homo sapiens	Inhibition	%	4.28
	8199594	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.23	CHEMBL4014	Homo sapiens	Inhibition	%	3.23
	8199757	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	15.29	CHEMBL4014	Homo sapiens	Inhibition	%	15.29
	8200119	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%		CHEMBL4014	Homo sapiens	Inhibition	%	
	8200447	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	3.8	CHEMBL4014	Homo sapiens	Inhibition	%	3.8
	8200562	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	9.97	CHEMBL4014	Homo sapiens	Inhibition	%	9.97
	8200936	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	34.06	CHEMBL4014	Homo sapiens	Inhibition	%	34.06
	8201066	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.54	CHEMBL4014	Homo sapiens	Inhibition	%	0.54
	8201290	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	18.45	CHEMBL4014	Homo sapiens	Inhibition	%	18.45
	8201425	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.51	CHEMBL4014	Homo sapiens	Inhibition	%	3.51
	8201782	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	5.58	CHEMBL4014	Homo sapiens	Inhibition	%	5.58
	8202061	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.19	CHEMBL4014	Homo sapiens	Inhibition	%	4.19
	8202201	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	21.05	CHEMBL4014	Homo sapiens	Inhibition	%	21.05
	8202425	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.45	CHEMBL4014	Homo sapiens	Inhibition	%	0.45
	8202592	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.56	CHEMBL4014	Homo sapiens	Inhibition	%	4.56
	8202717	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.48	CHEMBL4014	Homo sapiens	Inhibition	%	2.48
	8202941	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	7.82	CHEMBL4014	Homo sapiens	Inhibition	%	7.82
	8203071	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.49	CHEMBL4014	Homo sapiens	Inhibition	%	4.49
	8203426	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	19.51	CHEMBL4014	Homo sapiens	Inhibition	%	19.51
	8203572	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	7.06	CHEMBL4014	Homo sapiens	Inhibition	%	7.06
	8203930	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.72	CHEMBL4014	Homo sapiens	Inhibition	%	1.72
	8204096	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	8.31	CHEMBL4014	Homo sapiens	Inhibition	%	8.31
	8204320	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	36.2	CHEMBL4014	Homo sapiens	Inhibition	%	36.2
	8204457	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	74.31	CHEMBL4014	Homo sapiens	Inhibition	%	74.31
	8204786	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	18.22	CHEMBL4014	Homo sapiens	Inhibition	%	18.22
	8204901	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	15.55	CHEMBL4014	Homo sapiens	Inhibition	%	15.55
	8205125	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	65.74	CHEMBL4014	Homo sapiens	Inhibition	%	65.74
	8205274	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.73	CHEMBL4014	Homo sapiens	Inhibition	%	3.73
	8205634	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.48	CHEMBL4014	Homo sapiens	Inhibition	%	3.48
	8205773	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	6.27	CHEMBL4014	Homo sapiens	Inhibition	%	6.27
	8205997	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	8.79	CHEMBL4014	Homo sapiens	Inhibition	%	8.79
	8206129	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	12.13	CHEMBL4014	Homo sapiens	Inhibition	%	12.13
	8206405	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.05	CHEMBL4014	Homo sapiens	Inhibition	%	4.05
	8206772	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	9.86	CHEMBL4014	Homo sapiens	Inhibition	%	9.86
	8206952	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.56	CHEMBL4014	Homo sapiens	Inhibition	%	3.56
	8207302	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.3	CHEMBL4014	Homo sapiens	Inhibition	%	3.3
	8207432	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.54	CHEMBL4014	Homo sapiens	Inhibition	%	5.54
	8207788	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	62.75	CHEMBL4014	Homo sapiens	Inhibition	%	62.75
	8207933	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.25	CHEMBL4014	Homo sapiens	Inhibition	%	2.25
	8208157	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.19	CHEMBL4014	Homo sapiens	Inhibition	%	1.19
	8208289	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.35	CHEMBL4014	Homo sapiens	Inhibition	%	3.35
	8208679	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.07	CHEMBL4014	Homo sapiens	Inhibition	%	3.07
	8208812	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	95.72	CHEMBL4014	Homo sapiens	Inhibition	%	95.72
	8209141	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	7.9	CHEMBL4014	Homo sapiens	Inhibition	%	7.9
	8209481	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.71	CHEMBL4014	Homo sapiens	Inhibition	%	3.71
	8209631	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	9.11	CHEMBL4014	Homo sapiens	Inhibition	%	9.11
	8209855	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	6.43	CHEMBL4014	Homo sapiens	Inhibition	%	6.43
	8209991	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	11.16	CHEMBL4014	Homo sapiens	Inhibition	%	11.16
	8210356	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	7.68	CHEMBL4014	Homo sapiens	Inhibition	%	7.68
	8210492	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.08	CHEMBL4014	Homo sapiens	Inhibition	%	-0.08
	8210751	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.31	CHEMBL4014	Homo sapiens	Inhibition	%	-0.31
	8211119	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.44	CHEMBL4014	Homo sapiens	Inhibition	%	3.44
	8211289	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-5.79	CHEMBL4014	Homo sapiens	Inhibition	%	-5.79
	8211636	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.05	CHEMBL4014	Homo sapiens	Inhibition	%	7.05
	8211765	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.68	CHEMBL4014	Homo sapiens	Inhibition	%	7.68
	8211989	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	25.73	CHEMBL4014	Homo sapiens	Inhibition	%	25.73
	8212121	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.36	CHEMBL4014	Homo sapiens	Inhibition	%	4.36
	8212486	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.46	CHEMBL4014	Homo sapiens	Inhibition	%	3.46
	8212619	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	35.59	CHEMBL4014	Homo sapiens	Inhibition	%	35.59
	8212843	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.81	CHEMBL4014	Homo sapiens	Inhibition	%	3.81
	8213013	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	8.71	CHEMBL4014	Homo sapiens	Inhibition	%	8.71
	8213142	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.44	CHEMBL4014	Homo sapiens	Inhibition	%	3.44
	8213366	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.37	CHEMBL4014	Homo sapiens	Inhibition	%	5.37
	8213470	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	65.09	CHEMBL4014	Homo sapiens	Inhibition	%	65.09
	8213807	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	8.87	CHEMBL4014	Homo sapiens	Inhibition	%	8.87
	8214178	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	7.09	CHEMBL4014	Homo sapiens	Inhibition	%	7.09
	8214315	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.99	CHEMBL4014	Homo sapiens	Inhibition	%	4.99
	8214673	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	50.75	CHEMBL4014	Homo sapiens	Inhibition	%	50.75
	8214825	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.5	CHEMBL4014	Homo sapiens	Inhibition	%	2.5
	8215076	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.57	CHEMBL4014	Homo sapiens	Inhibition	%	2.57
	8215300	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.67	CHEMBL4014	Homo sapiens	Inhibition	%	2.67
	8215453	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	5.92	CHEMBL4014	Homo sapiens	Inhibition	%	5.92
	8215617	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.18	CHEMBL4014	Homo sapiens	Inhibition	%	1.18
	8215841	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.47	CHEMBL4014	Homo sapiens	Inhibition	%	1.47
	8215960	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-1.39	CHEMBL4014	Homo sapiens	Inhibition	%	-1.39
	8216303	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.79	CHEMBL4014	Homo sapiens	Inhibition	%	1.79
	8216439	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	15.18	CHEMBL4014	Homo sapiens	Inhibition	%	15.18
	8216663	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.63	CHEMBL4014	Homo sapiens	Inhibition	%	2.63
	8216801	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	12.26	CHEMBL4014	Homo sapiens	Inhibition	%	12.26
	8217159	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	9.01	CHEMBL4014	Homo sapiens	Inhibition	%	9.01
	8217333	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.49	CHEMBL4014	Homo sapiens	Inhibition	%	1.49
	8217688	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.77	CHEMBL4014	Homo sapiens	Inhibition	%	4.77
	8217789	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.74	CHEMBL4014	Homo sapiens	Inhibition	%	-0.74
	8218013	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	7.37	CHEMBL4014	Homo sapiens	Inhibition	%	7.37
	8218128	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.57	CHEMBL4014	Homo sapiens	Inhibition	%	4.57
	8218479	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	73.3	CHEMBL4014	Homo sapiens	Inhibition	%	73.3
	8218622	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	37.22	CHEMBL4014	Homo sapiens	Inhibition	%	37.22
	8218846	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	13.57	CHEMBL4014	Homo sapiens	Inhibition	%	13.57
	8218977	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	77.12	CHEMBL4014	Homo sapiens	Inhibition	%	77.12
	8219137	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.43	CHEMBL4014	Homo sapiens	Inhibition	%	5.43
	8219361	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	34.11	CHEMBL4014	Homo sapiens	Inhibition	%	34.11
	8219611	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.55	CHEMBL4014	Homo sapiens	Inhibition	%	0.55
	8219772	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.42	CHEMBL4014	Homo sapiens	Inhibition	%	3.42
	8220165	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.64	CHEMBL4014	Homo sapiens	Inhibition	%	4.64
	8220294	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.38	CHEMBL4014	Homo sapiens	Inhibition	%	1.38
	8220632	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.59	CHEMBL4014	Homo sapiens	Inhibition	%	2.59
	8220994	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	9.37	CHEMBL4014	Homo sapiens	Inhibition	%	9.37
	8221130	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.1	CHEMBL4014	Homo sapiens	Inhibition	%	-2.1
	8221487	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.02	CHEMBL4014	Homo sapiens	Inhibition	%	4.02
	8221652	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.49	CHEMBL4014	Homo sapiens	Inhibition	%	1.49
	8222007	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	17.96	CHEMBL4014	Homo sapiens	Inhibition	%	17.96
	8222329	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	13.0	CHEMBL4014	Homo sapiens	Inhibition	%	13.0
	8222463	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	19.37	CHEMBL4014	Homo sapiens	Inhibition	%	19.37
	8222687	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.93	CHEMBL4014	Homo sapiens	Inhibition	%	4.93
	8222805	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	82.05	CHEMBL4014	Homo sapiens	Inhibition	%	82.05
	8223173	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	68.07	CHEMBL4014	Homo sapiens	Inhibition	%	68.07
	8223302	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	25.05	CHEMBL4014	Homo sapiens	Inhibition	%	25.05
	8223687	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.27	CHEMBL4014	Homo sapiens	Inhibition	%	3.27
	8223937	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.97	CHEMBL4014	Homo sapiens	Inhibition	%	2.97
	8224099	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	8.31	CHEMBL4014	Homo sapiens	Inhibition	%	8.31
	8224323	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.85	CHEMBL4014	Homo sapiens	Inhibition	%	-0.85
	8224493	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	7.43	CHEMBL4014	Homo sapiens	Inhibition	%	7.43
	8224628	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.9	CHEMBL4014	Homo sapiens	Inhibition	%	2.9
	8224852	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-0.56	CHEMBL4014	Homo sapiens	Inhibition	%	-0.56
	8224966	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.63	CHEMBL4014	Homo sapiens	Inhibition	%	3.63
	8225324	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.93	CHEMBL4014	Homo sapiens	Inhibition	%	5.93
	8225462	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.96	CHEMBL4014	Homo sapiens	Inhibition	%	-2.96
	8225686	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.69	CHEMBL4014	Homo sapiens	Inhibition	%	0.69
	8225821	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.35	CHEMBL4014	Homo sapiens	Inhibition	%	5.35
	8225979	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.73	CHEMBL4014	Homo sapiens	Inhibition	%	-0.73
	8226203	CHEMBL1962243	GSK_PKIS: ARG mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	19.31	CHEMBL4014	Homo sapiens	Inhibition	%	19.31
	8226328	CHEMBL1962242	GSK_PKIS: ARG mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.79	CHEMBL4014	Homo sapiens	Inhibition	%	3.79
	10838551	CHEMBL2014124	Inhibition of ARG at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL4014	Homo sapiens	INH	%	0.0
Not Active	11022088	CHEMBL2090280	Inhibition of Arg at >1000 nM	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
	12046240	CHEMBL2157260	Inhibition of Arg at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	0.3	CHEMBL4014	Homo sapiens	INH	%	0.3
	12074618	CHEMBL2161015	Inhibition of Arg at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	12112606	CHEMBL2173305	Inhibition of ABL2 at 1 uM by 33P kinase hotspot assay	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	Inhibition	%	75.0	CHEMBL4014	Homo sapiens	INH	%	75.0
	12112607	CHEMBL2173305	Inhibition of ABL2 at 1 uM by 33P kinase hotspot assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	98.0	CHEMBL4014	Homo sapiens	INH	%	98.0
	12173751	CHEMBL2212089	Inhibition of ABL2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4014	Homo sapiens	Activity	%	100.0
	12185167	CHEMBL2216363	Inhibition of ABL2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4014	Homo sapiens	pIC50		5.0
	12207424	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	45.0	CHEMBL4014	Homo sapiens	Residual Activity	%	45.0
	12207425	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	104.0	CHEMBL4014	Homo sapiens	Residual Activity	%	104.0
	12207426	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	22.0	CHEMBL4014	Homo sapiens	Residual Activity	%	22.0
	12207427	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	101.0	CHEMBL4014	Homo sapiens	Residual Activity	%	101.0
	12207428	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	59.0	CHEMBL4014	Homo sapiens	Residual Activity	%	59.0
	12207429	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-2.0	CHEMBL4014	Homo sapiens	Residual Activity	%	-2.0
	12207430	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	113.0	CHEMBL4014	Homo sapiens	Residual Activity	%	113.0
	12207431	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	115.0	CHEMBL4014	Homo sapiens	Residual Activity	%	115.0
	12207432	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	87.0	CHEMBL4014	Homo sapiens	Residual Activity	%	87.0
	12207433	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	97.0	CHEMBL4014	Homo sapiens	Residual Activity	%	97.0
	12207434	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-3.0	CHEMBL4014	Homo sapiens	Residual Activity	%	-3.0
	12207435	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	62.0	CHEMBL4014	Homo sapiens	Residual Activity	%	62.0
	12207436	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	87.0	CHEMBL4014	Homo sapiens	Residual Activity	%	87.0
	12207437	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	52.0	CHEMBL4014	Homo sapiens	Residual Activity	%	52.0
	12207438	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	16.0	CHEMBL4014	Homo sapiens	Residual Activity	%	16.0
	12207439	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	102.0	CHEMBL4014	Homo sapiens	Residual Activity	%	102.0
	12207440	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	88.0	CHEMBL4014	Homo sapiens	Residual Activity	%	88.0
	12207441	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12207442	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	91.0	CHEMBL4014	Homo sapiens	Residual Activity	%	91.0
	12207443	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	12.0	CHEMBL4014	Homo sapiens	Residual Activity	%	12.0
	12207444	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	113.0	CHEMBL4014	Homo sapiens	Residual Activity	%	113.0
	12207445	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12207446	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	31.0	CHEMBL4014	Homo sapiens	Residual Activity	%	31.0
	12207447	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	99.0	CHEMBL4014	Homo sapiens	Residual Activity	%	99.0
	12207448	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	70.0	CHEMBL4014	Homo sapiens	Residual Activity	%	70.0
	12207449	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	104.0	CHEMBL4014	Homo sapiens	Residual Activity	%	104.0
	12207450	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	87.0	CHEMBL4014	Homo sapiens	Residual Activity	%	87.0
	12207451	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	75.0	CHEMBL4014	Homo sapiens	Residual Activity	%	75.0
	12207452	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	96.0	CHEMBL4014	Homo sapiens	Residual Activity	%	96.0
	12207453	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	101.0	CHEMBL4014	Homo sapiens	Residual Activity	%	101.0
	12207454	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	111.0	CHEMBL4014	Homo sapiens	Residual Activity	%	111.0
	12207455	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	104.0	CHEMBL4014	Homo sapiens	Residual Activity	%	104.0
	12207456	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	78.0	CHEMBL4014	Homo sapiens	Residual Activity	%	78.0
	12207457	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12207458	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	51.0	CHEMBL4014	Homo sapiens	Residual Activity	%	51.0
	12207459	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	25.0	CHEMBL4014	Homo sapiens	Residual Activity	%	25.0
	12207460	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	90.0	CHEMBL4014	Homo sapiens	Residual Activity	%	90.0
	12207461	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	114.0	CHEMBL4014	Homo sapiens	Residual Activity	%	114.0
	12207462	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	79.0	CHEMBL4014	Homo sapiens	Residual Activity	%	79.0
	12207463	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	95.0	CHEMBL4014	Homo sapiens	Residual Activity	%	95.0
	12207464	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	31.0	CHEMBL4014	Homo sapiens	Residual Activity	%	31.0
	12207465	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	10.0	CHEMBL4014	Homo sapiens	Residual Activity	%	10.0
	12207466	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	83.0	CHEMBL4014	Homo sapiens	Residual Activity	%	83.0
	12207467	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	14.0	CHEMBL4014	Homo sapiens	Residual Activity	%	14.0
	12207468	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	74.0	CHEMBL4014	Homo sapiens	Residual Activity	%	74.0
	12207469	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	103.0	CHEMBL4014	Homo sapiens	Residual Activity	%	103.0
	12207470	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	72.0	CHEMBL4014	Homo sapiens	Residual Activity	%	72.0
	12207471	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	18.0	CHEMBL4014	Homo sapiens	Residual Activity	%	18.0
	12207472	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	67.0	CHEMBL4014	Homo sapiens	Residual Activity	%	67.0
	12207473	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	99.0	CHEMBL4014	Homo sapiens	Residual Activity	%	99.0
	12207474	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	85.0	CHEMBL4014	Homo sapiens	Residual Activity	%	85.0
	12207475	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12207476	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	101.0	CHEMBL4014	Homo sapiens	Residual Activity	%	101.0
	12207477	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	100.0	CHEMBL4014	Homo sapiens	Residual Activity	%	100.0
	12207478	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	116.0	CHEMBL4014	Homo sapiens	Residual Activity	%	116.0
	12207479	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	58.0	CHEMBL4014	Homo sapiens	Residual Activity	%	58.0
	12207480	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	92.0	CHEMBL4014	Homo sapiens	Residual Activity	%	92.0
	12207481	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	84.0	CHEMBL4014	Homo sapiens	Residual Activity	%	84.0
	12207482	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	98.0	CHEMBL4014	Homo sapiens	Residual Activity	%	98.0
	12207483	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	4.0	CHEMBL4014	Homo sapiens	Residual Activity	%	4.0
	12207484	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	4.0	CHEMBL4014	Homo sapiens	Residual Activity	%	4.0
	12207485	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	22.0	CHEMBL4014	Homo sapiens	Residual Activity	%	22.0
	12207486	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	118.0	CHEMBL4014	Homo sapiens	Residual Activity	%	118.0
	12207487	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	60.0	CHEMBL4014	Homo sapiens	Residual Activity	%	60.0
	12207488	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	18.0	CHEMBL4014	Homo sapiens	Residual Activity	%	18.0
	12207489	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL4014	Homo sapiens	Residual Activity	%	-1.0
	12207490	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12207491	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	113.0	CHEMBL4014	Homo sapiens	Residual Activity	%	113.0
	12207492	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	106.0	CHEMBL4014	Homo sapiens	Residual Activity	%	106.0
	12207493	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL4014	Homo sapiens	Residual Activity	%	96.0
	12207494	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	1.0	CHEMBL4014	Homo sapiens	Residual Activity	%	1.0
	12207495	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	118.0	CHEMBL4014	Homo sapiens	Residual Activity	%	118.0
	12207496	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	97.0	CHEMBL4014	Homo sapiens	Residual Activity	%	97.0
	12207497	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	95.0	CHEMBL4014	Homo sapiens	Residual Activity	%	95.0
	12207498	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	122.0	CHEMBL4014	Homo sapiens	Residual Activity	%	122.0
	12207499	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL4014	Homo sapiens	Residual Activity	%	102.0
	12207500	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	69.0	CHEMBL4014	Homo sapiens	Residual Activity	%	69.0
	12207501	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	11.0	CHEMBL4014	Homo sapiens	Residual Activity	%	11.0
	12207502	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	18.0	CHEMBL4014	Homo sapiens	Residual Activity	%	18.0
	12207503	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	72.0	CHEMBL4014	Homo sapiens	Residual Activity	%	72.0
	12207504	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	114.0	CHEMBL4014	Homo sapiens	Residual Activity	%	114.0
	12207505	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	81.0	CHEMBL4014	Homo sapiens	Residual Activity	%	81.0
	12207506	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	113.0	CHEMBL4014	Homo sapiens	Residual Activity	%	113.0
	12207507	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	102.0	CHEMBL4014	Homo sapiens	Residual Activity	%	102.0
	12207508	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	74.0	CHEMBL4014	Homo sapiens	Residual Activity	%	74.0
	12207509	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	21.0	CHEMBL4014	Homo sapiens	Residual Activity	%	21.0
	12207510	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	33.0	CHEMBL4014	Homo sapiens	Residual Activity	%	33.0
	12207511	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	92.0	CHEMBL4014	Homo sapiens	Residual Activity	%	92.0
	12207512	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	92.0	CHEMBL4014	Homo sapiens	Residual Activity	%	92.0
	12207513	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	94.0	CHEMBL4014	Homo sapiens	Residual Activity	%	94.0
	12207514	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12207515	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	74.0	CHEMBL4014	Homo sapiens	Residual Activity	%	74.0
	12207516	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12207517	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	83.0	CHEMBL4014	Homo sapiens	Residual Activity	%	83.0
	12207518	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	42.0	CHEMBL4014	Homo sapiens	Residual Activity	%	42.0
	12207519	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	45.0	CHEMBL4014	Homo sapiens	Residual Activity	%	45.0
	12207520	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	107.0	CHEMBL4014	Homo sapiens	Residual Activity	%	107.0
	12207521	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	98.0	CHEMBL4014	Homo sapiens	Residual Activity	%	98.0
	12207522	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12207523	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12207524	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	105.0	CHEMBL4014	Homo sapiens	Residual Activity	%	105.0
	12207525	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	101.0	CHEMBL4014	Homo sapiens	Residual Activity	%	101.0
	12207526	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	86.0	CHEMBL4014	Homo sapiens	Residual Activity	%	86.0
	12207527	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12207528	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	103.0	CHEMBL4014	Homo sapiens	Residual Activity	%	103.0
	12207529	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	44.0	CHEMBL4014	Homo sapiens	Residual Activity	%	44.0
	12207530	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	76.0	CHEMBL4014	Homo sapiens	Residual Activity	%	76.0
	12207531	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	96.0	CHEMBL4014	Homo sapiens	Residual Activity	%	96.0
	12207532	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	8.0	CHEMBL4014	Homo sapiens	Residual Activity	%	8.0
	12207533	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	61.0	CHEMBL4014	Homo sapiens	Residual Activity	%	61.0
	12207534	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	98.0	CHEMBL4014	Homo sapiens	Residual Activity	%	98.0
	12207535	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	7.0	CHEMBL4014	Homo sapiens	Residual Activity	%	7.0
	12207536	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	84.0	CHEMBL4014	Homo sapiens	Residual Activity	%	84.0
	12207537	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL4014	Homo sapiens	Residual Activity	%	-1.0
	12207538	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12207539	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	8.0	CHEMBL4014	Homo sapiens	Residual Activity	%	8.0
	12207540	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	87.0	CHEMBL4014	Homo sapiens	Residual Activity	%	87.0
	12207541	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	100.0	CHEMBL4014	Homo sapiens	Residual Activity	%	100.0
	12207542	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	75.0	CHEMBL4014	Homo sapiens	Residual Activity	%	75.0
	12207543	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	86.0	CHEMBL4014	Homo sapiens	Residual Activity	%	86.0
	12207544	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12207545	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	55.0	CHEMBL4014	Homo sapiens	Residual Activity	%	55.0
	12207546	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	90.0	CHEMBL4014	Homo sapiens	Residual Activity	%	90.0
	12207547	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	28.0	CHEMBL4014	Homo sapiens	Residual Activity	%	28.0
	12207548	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	84.0	CHEMBL4014	Homo sapiens	Residual Activity	%	84.0
	12207549	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	18.0	CHEMBL4014	Homo sapiens	Residual Activity	%	18.0
	12207550	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	3.0	CHEMBL4014	Homo sapiens	Residual Activity	%	3.0
	12207551	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	86.0	CHEMBL4014	Homo sapiens	Residual Activity	%	86.0
	12207552	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	53.0	CHEMBL4014	Homo sapiens	Residual Activity	%	53.0
	12207553	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	80.0	CHEMBL4014	Homo sapiens	Residual Activity	%	80.0
	12207554	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12207555	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	97.0	CHEMBL4014	Homo sapiens	Residual Activity	%	97.0
	12207556	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	91.0	CHEMBL4014	Homo sapiens	Residual Activity	%	91.0
	12207557	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	64.0	CHEMBL4014	Homo sapiens	Residual Activity	%	64.0
	12207558	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	56.0	CHEMBL4014	Homo sapiens	Residual Activity	%	56.0
	12207559	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	35.0	CHEMBL4014	Homo sapiens	Residual Activity	%	35.0
	12207560	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	74.0	CHEMBL4014	Homo sapiens	Residual Activity	%	74.0
	12207561	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12207562	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	76.0	CHEMBL4014	Homo sapiens	Residual Activity	%	76.0
	12207563	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12207564	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	81.0	CHEMBL4014	Homo sapiens	Residual Activity	%	81.0
	12207565	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	87.0	CHEMBL4014	Homo sapiens	Residual Activity	%	87.0
	12207566	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	77.0	CHEMBL4014	Homo sapiens	Residual Activity	%	77.0
	12207567	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	45.0	CHEMBL4014	Homo sapiens	Residual Activity	%	45.0
	12207568	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	46.0	CHEMBL4014	Homo sapiens	Residual Activity	%	46.0
	12207569	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	45.0	CHEMBL4014	Homo sapiens	Residual Activity	%	45.0
	12207570	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	17.0	CHEMBL4014	Homo sapiens	Residual Activity	%	17.0
	12207571	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	66.0	CHEMBL4014	Homo sapiens	Residual Activity	%	66.0
	12207572	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	95.0	CHEMBL4014	Homo sapiens	Residual Activity	%	95.0
	12207573	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL4014	Homo sapiens	Residual Activity	%	90.0
	12207574	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	19.0	CHEMBL4014	Homo sapiens	Residual Activity	%	19.0
	12207575	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	87.0	CHEMBL4014	Homo sapiens	Residual Activity	%	87.0
	12207576	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	65.0	CHEMBL4014	Homo sapiens	Residual Activity	%	65.0
	12207577	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	77.0	CHEMBL4014	Homo sapiens	Residual Activity	%	77.0
	12207578	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	60.0	CHEMBL4014	Homo sapiens	Residual Activity	%	60.0
	12207579	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	13.0	CHEMBL4014	Homo sapiens	Residual Activity	%	13.0
	12207580	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	10.0	CHEMBL4014	Homo sapiens	Residual Activity	%	10.0
	12207581	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	71.0	CHEMBL4014	Homo sapiens	Residual Activity	%	71.0
	12207582	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	18.0	CHEMBL4014	Homo sapiens	Residual Activity	%	18.0
	12207583	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12207584	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	1.0	CHEMBL4014	Homo sapiens	Residual Activity	%	1.0
	12207585	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	72.0	CHEMBL4014	Homo sapiens	Residual Activity	%	72.0
	12207586	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	53.0	CHEMBL4014	Homo sapiens	Residual Activity	%	53.0
	12207587	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-2.0	CHEMBL4014	Homo sapiens	Residual Activity	%	-2.0
	12207588	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	76.0	CHEMBL4014	Homo sapiens	Residual Activity	%	76.0
	12207589	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	85.0	CHEMBL4014	Homo sapiens	Residual Activity	%	85.0
	12207590	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	72.0	CHEMBL4014	Homo sapiens	Residual Activity	%	72.0
	12207591	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	83.0	CHEMBL4014	Homo sapiens	Residual Activity	%	83.0
	12207592	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-2.0	CHEMBL4014	Homo sapiens	Residual Activity	%	-2.0
	12207593	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	8.0	CHEMBL4014	Homo sapiens	Residual Activity	%	8.0
	12207594	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	83.0	CHEMBL4014	Homo sapiens	Residual Activity	%	83.0
	12207595	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	9.0	CHEMBL4014	Homo sapiens	Residual Activity	%	9.0
	12207596	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	2.0	CHEMBL4014	Homo sapiens	Residual Activity	%	2.0
	12207597	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	86.0	CHEMBL4014	Homo sapiens	Residual Activity	%	86.0
	12207598	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12207599	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	77.0	CHEMBL4014	Homo sapiens	Residual Activity	%	77.0
	12207600	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	74.0	CHEMBL4014	Homo sapiens	Residual Activity	%	74.0
	12207601	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	1.0	CHEMBL4014	Homo sapiens	Residual Activity	%	1.0
	12207602	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	83.0	CHEMBL4014	Homo sapiens	Residual Activity	%	83.0
	12207603	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	64.0	CHEMBL4014	Homo sapiens	Residual Activity	%	64.0
	12207604	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	4.0	CHEMBL4014	Homo sapiens	Residual Activity	%	4.0
	12207605	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	76.0	CHEMBL4014	Homo sapiens	Residual Activity	%	76.0
	12207606	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	30.0	CHEMBL4014	Homo sapiens	Residual Activity	%	30.0
	12207607	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	75.0	CHEMBL4014	Homo sapiens	Residual Activity	%	75.0
	12207608	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	47.0	CHEMBL4014	Homo sapiens	Residual Activity	%	47.0
	12207609	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	53.0	CHEMBL4014	Homo sapiens	Residual Activity	%	53.0
	12207610	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	83.0	CHEMBL4014	Homo sapiens	Residual Activity	%	83.0
	12207611	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12207612	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12207613	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	78.0	CHEMBL4014	Homo sapiens	Residual Activity	%	78.0
	12207614	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	41.0	CHEMBL4014	Homo sapiens	Residual Activity	%	41.0
	12207615	CHEMBL2218947	Millipore: Percentage of residual kinase activity of ABL2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	55.0	CHEMBL4014	Homo sapiens	Residual Activity	%	55.0
	12249616	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	88.0	CHEMBL4014	Homo sapiens	Residual Activity	%	88.0
	12249617	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	78.0	CHEMBL4014	Homo sapiens	Residual Activity	%	78.0
	12249618	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	92.0	CHEMBL4014	Homo sapiens	Residual Activity	%	92.0
	12249619	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	85.0	CHEMBL4014	Homo sapiens	Residual Activity	%	85.0
	12249620	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12249621	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	103.0	CHEMBL4014	Homo sapiens	Residual Activity	%	103.0
	12249622	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	57.0	CHEMBL4014	Homo sapiens	Residual Activity	%	57.0
	12249623	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	48.0	CHEMBL4014	Homo sapiens	Residual Activity	%	48.0
	12249624	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	95.0	CHEMBL4014	Homo sapiens	Residual Activity	%	95.0
	12249625	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	42.0	CHEMBL4014	Homo sapiens	Residual Activity	%	42.0
	12249626	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	118.0	CHEMBL4014	Homo sapiens	Residual Activity	%	118.0
	12249627	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	100.0	CHEMBL4014	Homo sapiens	Residual Activity	%	100.0
	12249628	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	96.0	CHEMBL4014	Homo sapiens	Residual Activity	%	96.0
	12249629	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	68.0	CHEMBL4014	Homo sapiens	Residual Activity	%	68.0
	12249630	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12249631	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	101.0	CHEMBL4014	Homo sapiens	Residual Activity	%	101.0
	12249632	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	112.0	CHEMBL4014	Homo sapiens	Residual Activity	%	112.0
	12249633	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	92.0	CHEMBL4014	Homo sapiens	Residual Activity	%	92.0
	12249634	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	126.0	CHEMBL4014	Homo sapiens	Residual Activity	%	126.0
	12249635	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	128.0	CHEMBL4014	Homo sapiens	Residual Activity	%	128.0
	12249636	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	124.0	CHEMBL4014	Homo sapiens	Residual Activity	%	124.0
	12249637	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	90.0	CHEMBL4014	Homo sapiens	Residual Activity	%	90.0
	12249638	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	104.0	CHEMBL4014	Homo sapiens	Residual Activity	%	104.0
	12249639	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	110.0	CHEMBL4014	Homo sapiens	Residual Activity	%	110.0
	12249640	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	131.0	CHEMBL4014	Homo sapiens	Residual Activity	%	131.0
	12249641	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	36.0	CHEMBL4014	Homo sapiens	Residual Activity	%	36.0
	12249642	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	27.0	CHEMBL4014	Homo sapiens	Residual Activity	%	27.0
	12249643	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	76.0	CHEMBL4014	Homo sapiens	Residual Activity	%	76.0
	12249644	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	110.0	CHEMBL4014	Homo sapiens	Residual Activity	%	110.0
	12249645	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	111.0	CHEMBL4014	Homo sapiens	Residual Activity	%	111.0
	12249646	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	64.0	CHEMBL4014	Homo sapiens	Residual Activity	%	64.0
	12249647	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-2.0	CHEMBL4014	Homo sapiens	Residual Activity	%	-2.0
	12249648	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	117.0	CHEMBL4014	Homo sapiens	Residual Activity	%	117.0
	12249649	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	116.0	CHEMBL4014	Homo sapiens	Residual Activity	%	116.0
	12249650	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	113.0	CHEMBL4014	Homo sapiens	Residual Activity	%	113.0
	12249651	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	97.0	CHEMBL4014	Homo sapiens	Residual Activity	%	97.0
	12249652	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	12.0	CHEMBL4014	Homo sapiens	Residual Activity	%	12.0
	12249653	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	119.0	CHEMBL4014	Homo sapiens	Residual Activity	%	119.0
	12249654	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	108.0	CHEMBL4014	Homo sapiens	Residual Activity	%	108.0
	12249655	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	94.0	CHEMBL4014	Homo sapiens	Residual Activity	%	94.0
	12249656	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	140.0	CHEMBL4014	Homo sapiens	Residual Activity	%	140.0
	12249657	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	110.0	CHEMBL4014	Homo sapiens	Residual Activity	%	110.0
	12249658	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	85.0	CHEMBL4014	Homo sapiens	Residual Activity	%	85.0
	12249659	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	59.0	CHEMBL4014	Homo sapiens	Residual Activity	%	59.0
	12249660	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	50.0	CHEMBL4014	Homo sapiens	Residual Activity	%	50.0
	12249661	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	110.0	CHEMBL4014	Homo sapiens	Residual Activity	%	110.0
	12249662	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	106.0	CHEMBL4014	Homo sapiens	Residual Activity	%	106.0
	12249663	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	88.0	CHEMBL4014	Homo sapiens	Residual Activity	%	88.0
	12249664	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	110.0	CHEMBL4014	Homo sapiens	Residual Activity	%	110.0
	12249665	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	99.0	CHEMBL4014	Homo sapiens	Residual Activity	%	99.0
	12249666	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	113.0	CHEMBL4014	Homo sapiens	Residual Activity	%	113.0
	12249667	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	80.0	CHEMBL4014	Homo sapiens	Residual Activity	%	80.0
	12249668	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12249669	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	106.0	CHEMBL4014	Homo sapiens	Residual Activity	%	106.0
	12249670	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	105.0	CHEMBL4014	Homo sapiens	Residual Activity	%	105.0
	12249671	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	88.0	CHEMBL4014	Homo sapiens	Residual Activity	%	88.0
	12249672	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	124.0	CHEMBL4014	Homo sapiens	Residual Activity	%	124.0
	12249673	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12249674	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	115.0	CHEMBL4014	Homo sapiens	Residual Activity	%	115.0
	12249675	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	108.0	CHEMBL4014	Homo sapiens	Residual Activity	%	108.0
	12249676	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	80.0	CHEMBL4014	Homo sapiens	Residual Activity	%	80.0
	12249677	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	77.0	CHEMBL4014	Homo sapiens	Residual Activity	%	77.0
	12249678	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12249679	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	98.0	CHEMBL4014	Homo sapiens	Residual Activity	%	98.0
	12249680	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	88.0	CHEMBL4014	Homo sapiens	Residual Activity	%	88.0
	12249681	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	103.0	CHEMBL4014	Homo sapiens	Residual Activity	%	103.0
	12249682	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	111.0	CHEMBL4014	Homo sapiens	Residual Activity	%	111.0
	12249683	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	97.0	CHEMBL4014	Homo sapiens	Residual Activity	%	97.0
	12249684	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	89.0	CHEMBL4014	Homo sapiens	Residual Activity	%	89.0
	12249685	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12249686	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	96.0	CHEMBL4014	Homo sapiens	Residual Activity	%	96.0
	12249687	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	46.0	CHEMBL4014	Homo sapiens	Residual Activity	%	46.0
	12249688	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	90.0	CHEMBL4014	Homo sapiens	Residual Activity	%	90.0
	12249689	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	103.0	CHEMBL4014	Homo sapiens	Residual Activity	%	103.0
	12249690	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	46.0	CHEMBL4014	Homo sapiens	Residual Activity	%	46.0
	12249691	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	76.0	CHEMBL4014	Homo sapiens	Residual Activity	%	76.0
	12249692	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	94.0	CHEMBL4014	Homo sapiens	Residual Activity	%	94.0
	12249693	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	47.0	CHEMBL4014	Homo sapiens	Residual Activity	%	47.0
	12249694	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	99.0	CHEMBL4014	Homo sapiens	Residual Activity	%	99.0
	12249695	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4014	Homo sapiens	Residual Activity	%	1.0
	12249696	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL4014	Homo sapiens	Residual Activity	%	101.0
	12249697	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	34.0	CHEMBL4014	Homo sapiens	Residual Activity	%	34.0
	12249698	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	109.0	CHEMBL4014	Homo sapiens	Residual Activity	%	109.0
	12249699	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	107.0	CHEMBL4014	Homo sapiens	Residual Activity	%	107.0
	12249700	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	114.0	CHEMBL4014	Homo sapiens	Residual Activity	%	114.0
	12249701	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL4014	Homo sapiens	Residual Activity	%	105.0
	12249702	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	113.0	CHEMBL4014	Homo sapiens	Residual Activity	%	113.0
	12249703	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	86.0	CHEMBL4014	Homo sapiens	Residual Activity	%	86.0
	12249704	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	97.0	CHEMBL4014	Homo sapiens	Residual Activity	%	97.0
	12249705	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	30.0	CHEMBL4014	Homo sapiens	Residual Activity	%	30.0
	12249706	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	116.0	CHEMBL4014	Homo sapiens	Residual Activity	%	116.0
	12249707	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	66.0	CHEMBL4014	Homo sapiens	Residual Activity	%	66.0
	12249708	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	33.0	CHEMBL4014	Homo sapiens	Residual Activity	%	33.0
	12249709	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	106.0	CHEMBL4014	Homo sapiens	Residual Activity	%	106.0
	12249710	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	105.0	CHEMBL4014	Homo sapiens	Residual Activity	%	105.0
	12249711	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	94.0	CHEMBL4014	Homo sapiens	Residual Activity	%	94.0
	12249712	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	115.0	CHEMBL4014	Homo sapiens	Residual Activity	%	115.0
	12249713	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	91.0	CHEMBL4014	Homo sapiens	Residual Activity	%	91.0
	12249714	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	122.0	CHEMBL4014	Homo sapiens	Residual Activity	%	122.0
	12249715	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	95.0	CHEMBL4014	Homo sapiens	Residual Activity	%	95.0
	12249716	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	91.0	CHEMBL4014	Homo sapiens	Residual Activity	%	91.0
	12249717	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	79.0	CHEMBL4014	Homo sapiens	Residual Activity	%	79.0
	12249718	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	115.0	CHEMBL4014	Homo sapiens	Residual Activity	%	115.0
	12249719	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	103.0	CHEMBL4014	Homo sapiens	Residual Activity	%	103.0
	12249720	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	81.0	CHEMBL4014	Homo sapiens	Residual Activity	%	81.0
	12249721	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	93.0	CHEMBL4014	Homo sapiens	Residual Activity	%	93.0
	12249722	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	99.0	CHEMBL4014	Homo sapiens	Residual Activity	%	99.0
	12249723	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	111.0	CHEMBL4014	Homo sapiens	Residual Activity	%	111.0
	12249724	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	123.0	CHEMBL4014	Homo sapiens	Residual Activity	%	123.0
	12249725	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	76.0	CHEMBL4014	Homo sapiens	Residual Activity	%	76.0
	12249726	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	82.0	CHEMBL4014	Homo sapiens	Residual Activity	%	82.0
	12249727	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	62.0	CHEMBL4014	Homo sapiens	Residual Activity	%	62.0
	12249728	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	48.0	CHEMBL4014	Homo sapiens	Residual Activity	%	48.0
	12249729	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	116.0	CHEMBL4014	Homo sapiens	Residual Activity	%	116.0
	12249730	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	128.0	CHEMBL4014	Homo sapiens	Residual Activity	%	128.0
	12249731	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	118.0	CHEMBL4014	Homo sapiens	Residual Activity	%	118.0
	12249732	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	71.0	CHEMBL4014	Homo sapiens	Residual Activity	%	71.0
	12249733	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	116.0	CHEMBL4014	Homo sapiens	Residual Activity	%	116.0
	12249734	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	108.0	CHEMBL4014	Homo sapiens	Residual Activity	%	108.0
	12249735	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	96.0	CHEMBL4014	Homo sapiens	Residual Activity	%	96.0
	12249736	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	75.0	CHEMBL4014	Homo sapiens	Residual Activity	%	75.0
	12249737	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	62.0	CHEMBL4014	Homo sapiens	Residual Activity	%	62.0
	12249738	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	52.0	CHEMBL4014	Homo sapiens	Residual Activity	%	52.0
	12249739	CHEMBL2218946	Millipore: Percentage of residual kinase activity of ABL2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	112.0	CHEMBL4014	Homo sapiens	Residual Activity	%	112.0
	12626717	CHEMBL2316989	Inhibition of ABL2 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL4014	Homo sapiens	INH	%	80.0
	12657837	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	Cc1ccc(NC(=O)c2ccc(Cn3ccnc3)c(C(F)(F)F)c2)cc1C#Cc1cncnc1		CHEMBL2324932	=	IC50	nM	40.0	CHEMBL4014	Homo sapiens	IC50	nM	40.0
	12657839	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	Cc1ccc(NC(=O)c2ccc(Cn3ccnc3)c(C(F)(F)F)c2)cc1C#Cc1cncnc1		CHEMBL2324932	=	IC50	nM	163.0	CHEMBL4014	Homo sapiens	IC50	nM	163.0
	12657841	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(CCO)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2ccccn12		CHEMBL2324931	=	IC50	nM	18.0	CHEMBL4014	Homo sapiens	IC50	nM	18.0
	12657843	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(CCO)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2ccccn12		CHEMBL2324931	=	IC50	nM	41.0	CHEMBL4014	Homo sapiens	IC50	nM	41.0
	12657845	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL2324930	=	IC50	nM	8.0	CHEMBL4014	Homo sapiens	IC50	nM	8.0
	12657847	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL2324930	=	IC50	nM	39.0	CHEMBL4014	Homo sapiens	IC50	nM	39.0
	12657849	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4ccc(N)nc4)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324929	=	IC50	nM	36.0	CHEMBL4014	Homo sapiens	IC50	nM	36.0
	12657851	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4ccc(N)nc4)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324929	=	IC50	nM	67.0	CHEMBL4014	Homo sapiens	IC50	nM	67.0
	12657853	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cccnc4)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324928	=	IC50	nM	14.0	CHEMBL4014	Homo sapiens	IC50	nM	14.0
	12657855	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cccnc4)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324928	=	IC50	nM	66.0	CHEMBL4014	Homo sapiens	IC50	nM	66.0
	12657857	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5ccccn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324927	=	IC50	nM	12.0	CHEMBL4014	Homo sapiens	IC50	nM	12.0
	12657859	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5ccccn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324927	>	IC50	nM	10000.0	CHEMBL4014	Homo sapiens	IC50	nM	10000.0
	12657861	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	Cc1ccc(NC(=O)c2ccc(Cn3ccnc3)c(C(F)(F)F)c2)cc1C#Cc1ncc(Nc2ccccc2)cn1		CHEMBL2321908	=	IC50	nM	298.0	CHEMBL4014	Homo sapiens	IC50	nM	298.0
	12657863	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	Cc1ccc(NC(=O)c2ccc(Cn3ccnc3)c(C(F)(F)F)c2)cc1C#Cc1ncc(Nc2ccccc2)cn1		CHEMBL2321908	>	IC50	nM	10000.0	CHEMBL4014	Homo sapiens	IC50	nM	10000.0
	12657874	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5cccnn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324926	=	IC50	nM	6.0	CHEMBL4014	Homo sapiens	IC50	nM	6.0
	12657876	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5cccnn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324926	=	IC50	nM	47.0	CHEMBL4014	Homo sapiens	IC50	nM	47.0
	12657887	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5cnccn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324925	=	IC50	nM	10.0	CHEMBL4014	Homo sapiens	IC50	nM	10.0
	12657889	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cnc5cnccn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324925	=	IC50	nM	3.0	CHEMBL4014	Homo sapiens	IC50	nM	3.0
	12657900	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2nccn12		CHEMBL2324924	=	IC50	nM	1.0	CHEMBL4014	Homo sapiens	IC50	nM	1.0
	12657902	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cncc2nccn12		CHEMBL2324924	=	IC50	nM	2.0	CHEMBL4014	Homo sapiens	IC50	nM	2.0
	12657913	CHEMBL2330092	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cncc5nccn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324923	=	IC50	nM	15.0	CHEMBL4014	Homo sapiens	IC50	nM	15.0
	12657915	CHEMBL2330094	Inhibition of Abl2 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 mins by platform assay	B	CN1CCN(Cc2ccc(NC(=O)Nc3cc(C#Cc4cncc5nccn45)n(C)n3)cc2C(F)(F)F)CC1		CHEMBL2324923	=	IC50	nM	11.0	CHEMBL4014	Homo sapiens	IC50	nM	11.0
	12693260	CHEMBL2343945	Inhibition of ARG (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4014	Homo sapiens	IC50	nM	10000.0
	12728897	CHEMBL2350229	Inhibition of ARG (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	87.0	CHEMBL4014	Homo sapiens	Activity	%	87.0
	12730039	CHEMBL2353914	Inhibition of ARG (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL4014	Homo sapiens	Activity	%	99.0
	12730942	CHEMBL2350114	Inhibition of ABL2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	90.0	CHEMBL4014	Homo sapiens	Activity	%	90.0
	12731176	CHEMBL2350229	Inhibition of ARG (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	92.0	CHEMBL4014	Homo sapiens	Activity	%	92.0
	13301268	CHEMBL2384609	Inhibition of Arg (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1C(F)(F)F		CHEMBL2380834	=	IC50	nM	863.0	CHEMBL4014	Homo sapiens	IC50	nM	863.0
Not Active	13335959	CHEMBL2393924	Inhibition of ABL2 (unknown origin) transfected in mouse Ba/F3 cells up to 1 uM	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
Not Active	13336006	CHEMBL2394053	Inhibition of ABL2 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1		CHEMBL2390986		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
Active	13336007	CHEMBL2394053	Inhibition of ABL2 (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
Not Active	13336077	CHEMBL2394077	Inhibition of ABL2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL2390984		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
Not Active	13336078	CHEMBL2394077	Inhibition of ABL2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
Not Active	13336079	CHEMBL2394077	Inhibition of ABL2 (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1		CHEMBL167454		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
Not Active	13349238	CHEMBL2399730	Inhibition of recombinant ABL-2 (unknown origin) at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL2397148		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
Not Active	13349239	CHEMBL2399730	Inhibition of recombinant ABL-2 (unknown origin) at 10 uM	B	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL242459		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
	13372443	CHEMBL2406464	Inhibition of ARG (unknown origin) autophosphorylation at 1 uM	B	C[C@@H](Oc1c(N)ncc2c(C3=CCN(C(N)=O)CC3)coc12)c1c(Cl)ccc(F)c1Cl		CHEMBL2401832	>	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	13375955	CHEMBL2406115	Inhibition of ABL2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	4.0	CHEMBL4014	Homo sapiens	INH	%	4.0
	13419637	CHEMBL2422085	Inhibition of ARG (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	18.0	CHEMBL4014	Homo sapiens	INH	%	18.0
	13419638	CHEMBL2422085	Inhibition of ARG (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	13.0	CHEMBL4014	Homo sapiens	INH	%	13.0
	13419639	CHEMBL2422085	Inhibition of ARG (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	23.0	CHEMBL4014	Homo sapiens	INH	%	23.0
	13442407	CHEMBL2428030	Competitive binding affinity to ABL2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	13445542	CHEMBL2428030	Competitive binding affinity to ABL2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	13448597	CHEMBL2428030	Competitive binding affinity to ABL2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	13448734	CHEMBL2428030	Competitive binding affinity to ABL2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	13451529	CHEMBL2428030	Competitive binding affinity to ABL2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	89.0	CHEMBL4014	Homo sapiens	INH	%	89.0
	13454713	CHEMBL2428030	Competitive binding affinity to ABL2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	13872208	CHEMBL3102395	Inhibition of human Arg assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	98.0	CHEMBL4014	Homo sapiens	Activity	%	98.0
	13906514	CHEMBL3117706	Inhibition of ARG (unknown origin) at 10 uM after 30 mins relative to control	B	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC		CHEMBL3113284	=	Inhibition	%	8.2	CHEMBL4014	Homo sapiens	INH	%	8.2
	13954567	CHEMBL3132491	Inhibition of human ARG assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	60.0	CHEMBL4014	Homo sapiens	Activity	%	60.0
	13954771	CHEMBL3132491	Inhibition of human ARG assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	52.0	CHEMBL4014	Homo sapiens	Activity	%	52.0
	13954782	CHEMBL3132491	Inhibition of human ARG assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	38.0	CHEMBL4014	Homo sapiens	Activity	%	38.0
	13966007	CHEMBL3135932	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	33.0	CHEMBL4014	Homo sapiens	INH	%	33.0
	13966098	CHEMBL3134668	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	40.0	CHEMBL4014	Homo sapiens	INH	%	40.0
	13974000	CHEMBL3135900	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	1.5	CHEMBL4014	Homo sapiens	INH	%	1.5
	13974091	CHEMBL3135602	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	0.0	CHEMBL4014	Homo sapiens	INH	%	0.0
	13974182	CHEMBL3137122	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	6.5	CHEMBL4014	Homo sapiens	INH	%	6.5
	13974273	CHEMBL3136251	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	23.0	CHEMBL4014	Homo sapiens	INH	%	23.0
	13975011	CHEMBL3135307	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	54.5	CHEMBL4014	Homo sapiens	INH	%	54.5
	13975102	CHEMBL3135556	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	3.0	CHEMBL4014	Homo sapiens	INH	%	3.0
	13975193	CHEMBL3135782	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	5.0	CHEMBL4014	Homo sapiens	INH	%	5.0
	13975836	CHEMBL3134759	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	7.5	CHEMBL4014	Homo sapiens	INH	%	7.5
	13975927	CHEMBL3136401	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	3.5	CHEMBL4014	Homo sapiens	INH	%	3.5
	13976020	CHEMBL3135220	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	4.5	CHEMBL4014	Homo sapiens	INH	%	4.5
	13976111	CHEMBL3136782	Inhibition of human truncated Arg expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	50.5	CHEMBL4014	Homo sapiens	INH	%	50.5
	14582439	CHEMBL3240222	Inhibition of human Abl2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	108.0	CHEMBL4014	Homo sapiens	Activity	%	108.0
	14713702	CHEMBL3296767	Binding affinity to ARG (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	180.0	CHEMBL4014	Homo sapiens	Ki	uM	0.18
	14713738	CHEMBL3296856	Inhibition of ARG (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	76.0	CHEMBL4014	Homo sapiens	INH	%	76.0
Not Determined	14713760	CHEMBL3296767	Binding affinity to ARG (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Ki			CHEMBL4014	Homo sapiens	Ki		
Active	15008678	CHEMBL3364206	Binding affinity to ABL2 (unknown origin)	B	Cc1ccc(O)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321809		Activity			CHEMBL4014	Homo sapiens	Activity		
Active	15008679	CHEMBL3364206	Binding affinity to ABL2 (unknown origin)	B	NC(=O)c1c(N)n(-c2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321811		Activity			CHEMBL4014	Homo sapiens	Activity		
Active	15008680	CHEMBL3364206	Binding affinity to ABL2 (unknown origin)	B	NC(=O)c1c(N)n(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321816		Activity			CHEMBL4014	Homo sapiens	Activity		
	15014102	CHEMBL3361857	Inhibition of ARG (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	0.0	CHEMBL4014	Homo sapiens	INH	%	0.0
	15736628	CHEMBL3625823	Inhibition of human recombinant Arg	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL4014	Homo sapiens	IC50	uM	10.0
	15756121	CHEMBL3631607	Inhibition of ABL2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	99.83	CHEMBL4014	Homo sapiens	INH	%	99.83
	15757716	CHEMBL3631607	Inhibition of ABL2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	90.14	CHEMBL4014	Homo sapiens	INH	%	90.14
	15757978	CHEMBL3631607	Inhibition of ABL2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	59.29	CHEMBL4014	Homo sapiens	INH	%	59.29
	16431721	CHEMBL3749729	Inhibition of human ABL2 using [EAIYAAPFAKKK] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4014	Homo sapiens	IC50	uM	10.0
	16450763	CHEMBL3762149	Inhibition of ARG (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	69.5	CHEMBL4014	Homo sapiens	INH	%	69.5
	16495333	CHEMBL3776646	Inhibition of N-terminal His6-tagged recombinant ARG (unknown origin) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-15.0	CHEMBL4014	Homo sapiens	Activity	%	-15.0
	16508102	CHEMBL3776646	Inhibition of N-terminal His6-tagged recombinant ARG (unknown origin) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	20.0	CHEMBL4014	Homo sapiens	Activity	%	20.0
	16509079	CHEMBL3776646	Inhibition of N-terminal His6-tagged recombinant ARG (unknown origin) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	14.0	CHEMBL4014	Homo sapiens	Activity	%	14.0
	16593537	CHEMBL3811540	Inhibition of His-tagged full length human recombinant ARG expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4014	Homo sapiens	INH	%	40.0
	16613759	CHEMBL3816552	Inhibition of human ABL2 at 1 uM using [EAIYAAPFAKKK] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	4.0	CHEMBL4014	Homo sapiens	INH	%	4.0
	16618280	CHEMBL3817005	Inhibition of full length recombinant human C-terminal His-tagged cytoplasmic ARG expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	16619677	CHEMBL3820245	Inhibition of recombinant human full length His-tagged ARG expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL4014	Homo sapiens	INH	%	75.0
	16621477	CHEMBL3820470	Inhibition of ARG (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL4014	Homo sapiens	IC50	nM	30000.0
	16622192	CHEMBL3820470	Inhibition of ARG (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	75.9	CHEMBL4014	Homo sapiens	IC50	nM	75.9
	16737925	CHEMBL3856643	Inhibition of human recombinant ARG expressed in sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by Poly(Glu:Tyr) addition measured after 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	52.0	CHEMBL4014	Homo sapiens	Activity	%	52.0
	16844183	CHEMBL3877208	Inhibition of kinobead binding to ARG in human K562 cells incubated for 30 mins by iTRAQ reagent-based mass spectrometric method	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	272.0	CHEMBL4014	Homo sapiens	IC50	nM	272.0
Inactive	17878643	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878644	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878645	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878646	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878647	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878648	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878649	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878650	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878651	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878652	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	305.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	305.0
Inactive	17878653	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878654	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878655	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878656	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878657	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878658	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878659	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	10.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	10.0
Inactive	17878660	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878661	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878662	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878663	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Kd	nM	1508.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1508.0
Inactive	17878664	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878665	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878666	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	422.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	422.0
Inactive	17878667	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17878668	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	3754.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	3754.0
Inactive	17878669	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878670	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878671	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878672	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878673	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878674	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1293.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1293.0
Inactive	17878675	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878676	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878677	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878678	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878679	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878680	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878681	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	1372.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1372.0
Inactive	17878682	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878683	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878684	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878685	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878686	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878687	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878688	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878689	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878690	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878691	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878692	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878693	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878694	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878695	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878696	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878697	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878698	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878699	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878700	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878701	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878702	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878703	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878704	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878705	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878706	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	1480.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1480.0
Inactive	17878707	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878708	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878709	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878710	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878711	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878712	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878713	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1042.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1042.0
Inactive	17878714	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878715	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878716	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	40.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	40.0
Inactive	17878717	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878718	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878719	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	99.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	99.0
Inactive	17878720	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878721	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878722	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878723	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878724	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878725	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878726	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878727	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878728	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878729	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878730	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	291.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	291.0
Inactive	17878731	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878732	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878733	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878734	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	91.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	91.0
Active	17878735	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	302.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	302.0
Inactive	17878736	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878737	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	722.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	722.0
Inactive	17878738	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878739	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878740	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878741	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	347.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	347.0
Inactive	17878742	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878743	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878744	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878745	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878746	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878747	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878748	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878749	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878750	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	20.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	20.0
Inactive	17878751	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878752	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	54.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	54.0
Inactive	17878753	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878754	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878755	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	354.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	354.0
Inactive	17878756	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878757	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878758	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878759	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	Kd	nM	4058.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	4058.0
Active	17878760	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	427.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	427.0
Active	17878761	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	8.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	8.0
Inactive	17878762	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878763	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878764	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878765	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878766	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878767	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Kd	nM	1009.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1009.0
Inactive	17878768	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878769	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	64.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	64.0
Inactive	17878770	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878771	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878772	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878773	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878774	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	4.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	4.0
Inactive	17878775	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878776	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878777	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878778	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878779	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878780	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878781	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	918.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	918.0
Inactive	17878782	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878783	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878784	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878785	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878786	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	187.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	187.0
Inactive	17878787	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878788	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878789	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878790	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878791	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878792	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878793	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878794	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878795	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878796	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878797	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878798	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878799	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878800	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878801	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878802	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878803	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	30.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30.0
Inactive	17878804	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878805	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878806	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	135.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	135.0
Inactive	17878807	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878808	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878809	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878810	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878811	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878812	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878813	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878814	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878815	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878816	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878817	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878818	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878819	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1082.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1082.0
Inactive	17878820	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878821	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878822	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	77.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	77.0
Inactive	17878823	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878824	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878825	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878826	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878827	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	899.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	899.0
Active	17878828	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	919.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	919.0
Inactive	17878829	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878830	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878831	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878832	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878833	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878834	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	351.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	351.0
Inactive	17878835	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878836	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878837	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878838	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878839	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878840	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878841	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878842	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878843	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878844	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878845	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878846	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	1.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1.0
Inactive	17878847	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878848	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878849	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878850	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	20.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	20.0
Inactive	17878851	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878852	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878853	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	1034.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1034.0
Active	17878854	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	10.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	10.0
Active	17878855	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	315.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	315.0
Inactive	17878856	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878857	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878858	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878859	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878860	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878861	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878862	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878863	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878864	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1039.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	1039.0
Inactive	17878865	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878866	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878867	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878868	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878869	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	14924.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	14924.0
Active	17878870	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	=	Kd	nM	7071.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	7071.0
Inactive	17878871	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878872	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	628.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	628.0
Inactive	17878873	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878874	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Active	17878875	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	939.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	939.0
Inactive	17878876	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878877	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878878	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878879	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878880	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878881	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878882	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878883	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878884	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17878885	CHEMBL3991604	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4014	Homo sapiens	Kd apparent	nM	30000.0
	18053001	CHEMBL4011836	Inhibition of ARG (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-4.5	CHEMBL4014	Homo sapiens	INH	%	-4.5
	18057689	CHEMBL4012707	Inhibition of human wild type ABL2 (248 to 542 residues) expressed in bacterial expression system assessed as activity remaining at 1 uM by KINOMEscan assay relative to control	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	>	Activity	%	35.0	CHEMBL4014	Homo sapiens	Activity	%	35.0
	18114496	CHEMBL4024998	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL4014	Homo sapiens	Activity	%	100.0
	18153140	CHEMBL4034247	Inhibition of ARG (unknown origin) labeling at conserved Lysine1 at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	>	Inhibition	%	35.0	CHEMBL4014	Homo sapiens	INH	%	35.0
	18153356	CHEMBL4034246	Inhibition of ARG (unknown origin) labeling at activation loop at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-1.9	CHEMBL4014	Homo sapiens	INH	%	-1.9
	18203388	CHEMBL4043809	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	26.0	CHEMBL4014	Homo sapiens	Activity	%	26.0
	18211673	CHEMBL4045629	Inhibition of ARG labeling at conserved Lys1 (LMTGDTYTAHAGAKFPIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	34.8	CHEMBL4014	Homo sapiens	INH	%	34.8
	18211776	CHEMBL4045872	Inhibition of ARG labeling at conserved Lys1 (LMTGDTYTAHAGAKFPIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-5.2	CHEMBL4014	Homo sapiens	INH	%	-5.2
	18253602	CHEMBL4055085	Inhibition of wild-type human ARG (A248 to G542 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	91.0	CHEMBL4014	Homo sapiens	Activity	%	91.0
	18253603	CHEMBL4055085	Inhibition of wild-type human ARG (A248 to G542 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	91.0	CHEMBL4014	Homo sapiens	Activity	%	91.0
	18265924	CHEMBL4057374	Inhibition of Arg (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	66.3	CHEMBL4014	Homo sapiens	INH	%	66.3
	18266129	CHEMBL4057579	Inhibition of Arg (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	7.7	CHEMBL4014	Homo sapiens	INH	%	7.7
	18282690	CHEMBL4120275	Inhibition of Arg (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	66.3	CHEMBL4014	Homo sapiens	INH	%	66.3
	18282911	CHEMBL4120496	Inhibition of Arg (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	57.0	CHEMBL4014	Homo sapiens	INH	%	57.0
	18283131	CHEMBL4120716	Inhibition of Arg (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.7	CHEMBL4014	Homo sapiens	INH	%	0.7
	18440064	CHEMBL4156888	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	93.0	CHEMBL4014	Homo sapiens	Activity	%	93.0
	18463716	CHEMBL4181132	Inhibition of recombinant human N-terminal His6-tagged ARG (38 to end residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-7.0	CHEMBL4014	Homo sapiens	INH	%	-7.0
	18484504	CHEMBL4185667	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	78.0	CHEMBL4014	Homo sapiens	Activity	%	78.0
	18485117	CHEMBL4185667	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	95.0	CHEMBL4014	Homo sapiens	Activity	%	95.0
	18507899	CHEMBL4190867	Inhibition of recombinant human ARG (38 to end residues) at 1 uM using EAIYAAPFAKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	61.0	CHEMBL4014	Homo sapiens	INH	%	61.0
	18558662	CHEMBL4201056	Inhibition of human ABL2 at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	98.3	CHEMBL4014	Homo sapiens	INH	%	98.3
	18653767	CHEMBL4230020	Inhibition of ARG (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	99.0	CHEMBL4014	Homo sapiens	INH	%	99.0
	18653768	CHEMBL4230020	Inhibition of ARG (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	94.0	CHEMBL4014	Homo sapiens	INH	%	94.0
	18655653	CHEMBL4230567	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	69.0	CHEMBL4014	Homo sapiens	Activity	%	69.0
	18737839	CHEMBL4261400	Inhibition of recombinant human ARG (38 to end residues) using EAIYAAPFAKKK as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	306.0	CHEMBL4014	Homo sapiens	IC50	nM	306.0
	18751071	CHEMBL4263734	Inhibition of ARG (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	21.0	CHEMBL4014	Homo sapiens	INH	%	21.0
	18752058	CHEMBL4264156	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	77.0	CHEMBL4014	Homo sapiens	Activity	%	77.0
	18761500	CHEMBL4266523	Inhibition of recombinant human N-terminal His6-tagged Arg (38 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	-6.0	CHEMBL4014	Homo sapiens	INH	%	-6.0
	18761742	CHEMBL4266523	Inhibition of recombinant human N-terminal His6-tagged Arg (38 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	18.0	CHEMBL4014	Homo sapiens	INH	%	18.0
	18761905	CHEMBL4266523	Inhibition of recombinant human N-terminal His6-tagged Arg (38 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	15.0	CHEMBL4014	Homo sapiens	INH	%	15.0
	18778950	CHEMBL4269640	Inhibition of human ABL2 using EAIYAAPFAKKK as substrate at 1 uM by [gamma-33P]-ATP based assay relative to control	B	COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4293287	=	Inhibition	%	81.0	CHEMBL4014	Homo sapiens	INH	%	81.0
	18857793	CHEMBL4307673	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	98.0	CHEMBL4014	Homo sapiens	Activity	%	98.0
Active	18885181	CHEMBL4313107	Inhibition of recombinant human ARG (38 to end residues) at 100 nM using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	A	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12		CHEMBL4462946		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
	18892558	CHEMBL4314714	Inhibition of recombinant human ARG (38 to end residues) assessed as residual activity at 10 uM using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	115.0	CHEMBL4014	Homo sapiens	Activity	%	115.0
	18910093	CHEMBL4320887	Binding affinity to ABL2 (unknown origin)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	10.0	CHEMBL4014	Homo sapiens	pKd		8.0
	18919415	CHEMBL4322774	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged ABL2 (unknown origin) (2 to 52 and 74 to 1182 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	531.0	CHEMBL4014	Homo sapiens	Kd	nM	531.0
	18919603	CHEMBL4322774	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged ABL2 (unknown origin) (2 to 52 and 74 to 1182 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	947.0	CHEMBL4014	Homo sapiens	Kd	nM	947.0
	18937687	CHEMBL4327573	Inhibition of human ABL2 assessed as residual activity at 1 uM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.52	CHEMBL4014	Homo sapiens	Activity	%	97.52
	18937688	CHEMBL4327573	Inhibition of human ABL2 assessed as residual activity at 1 uM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.51	CHEMBL4014	Homo sapiens	Activity	%	93.51
	18938414	CHEMBL4327934	Inhibition of human ABL2 assessed as residual activity at 100 uM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4014	Homo sapiens	Activity	%	65.0
	18938779	CHEMBL4328298	Inhibition of human ABL2 using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.8	CHEMBL4014	Homo sapiens	IC50	10'-8M	1.58
	18958696	CHEMBL4333267	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	95.0	CHEMBL4014	Homo sapiens	Activity	%	95.0
	18964062	CHEMBL4334965	Inhibition of human Arg (38 to end residues) assessed as residual activity at 1 uM using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	87.0	CHEMBL4014	Homo sapiens	Activity	%	87.0
	18964063	CHEMBL4334965	Inhibition of human Arg (38 to end residues) assessed as residual activity at 1 uM using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	107.0	CHEMBL4014	Homo sapiens	Activity	%	107.0
	18971782	CHEMBL4336792	Inhibition of human Arg (38 to end residues) assessed as residual activity at 10 uM using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	1.0	CHEMBL4014	Homo sapiens	Activity	%	1.0
	19021454	CHEMBL4347674	Inhibition of recombinant human ARG at 20 nM using Ulight-TK peptide as substrate measured after 60 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	-3.0	CHEMBL4014	Homo sapiens	INH	%	-3.0
	19021455	CHEMBL4347675	Inhibition of recombinant human ARG at 200 nM using Ulight-TK peptide as substrate measured after 60 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	30.0	CHEMBL4014	Homo sapiens	INH	%	30.0
Not Active	19039900	CHEMBL4351743	Inhibition of recombinant human ARG (38 to end residues) at 10 uM using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
Active	19040999	CHEMBL4352260	Inhibition of human ABL2 at 10 uM using EAIYAAPFAKKK as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
	19059444	CHEMBL4357745	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	0.35	CHEMBL4014	Homo sapiens	Activity	%	0.35
	19090017	CHEMBL4365591	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	95.0	CHEMBL4014	Homo sapiens	Activity	%	95.0
	19091802	CHEMBL4366276	Inhibition of human ABL2 at 100 nM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-2.65	CHEMBL4014	Homo sapiens	INH	%	-2.65
	19095142	CHEMBL4367363	Inhibition of human ABL2 at 1 uM using EAIYAAPFAKKK as substrate in presence of [gamma-33P]ATP relative to control	B	CC(C)(C)S(=O)(=O)c1cc2c(Nc3ccc4scnc4c3)ncnc2cc1OCCO		CHEMBL4514780	=	Inhibition	%	70.0	CHEMBL4014	Homo sapiens	INH	%	70.0
	19114506	CHEMBL4371414	Binding affinity to ABL2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	71.0	CHEMBL4014	Homo sapiens	Kd(free)	uM	0.071
	19114686	CHEMBL4371414	Binding affinity to ABL2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	16.0	CHEMBL4014	Homo sapiens	Kd(free)	uM	0.016
	19125168	CHEMBL4373578	Inhibition of recombinant human N-terminal GST/His6-tagged ABL2 (M1 to P650 residues) expressed in sf9 cells assessed as equivalents of test compound required to show 50% inhibition using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918	=	Activity	equiv	456.7	CHEMBL4014	Homo sapiens	Activity	equiv	456.7
Dose-dependent effect	19125173	CHEMBL4373573	Inhibition of recombinant human N-terminal GST/His6-tagged ABL2 (M1 to P650 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918		Inhibition	%		CHEMBL4014	Homo sapiens	INH		
	19125178	CHEMBL4373573	Inhibition of recombinant human N-terminal GST/His6-tagged ABL2 (M1 to P650 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918	=	IC50	nM	685.0	CHEMBL4014	Homo sapiens	IC50	nM	685.0
	19125185	CHEMBL4373573	Inhibition of recombinant human N-terminal GST/His6-tagged ABL2 (M1 to P650 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	C[C@@H]1CN(C(=O)CCCC(=O)N2C[C@@H](C)c3c2cc(O)c2ccccc32)c2cc(O)c3ccccc3c21		CHEMBL4473548	=	IC50	nM	540.0	CHEMBL4014	Homo sapiens	IC50	nM	540.0
	19125190	CHEMBL4373578	Inhibition of recombinant human N-terminal GST/His6-tagged ABL2 (M1 to P650 residues) expressed in sf9 cells assessed as equivalents of test compound required to show 50% inhibition using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	C[C@@H]1CN(C(=O)CCCC(=O)N2C[C@@H](C)c3c2cc(O)c2ccccc32)c2cc(O)c3ccccc3c21		CHEMBL4473548	=	Activity	equiv	360.0	CHEMBL4014	Homo sapiens	Activity	equiv	360.0
	19146822	CHEMBL4378970	Inhibition of recombinant human ARG (38 to end residues) at 10 uM using EAIYAAPFAKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	16.0	CHEMBL4014	Homo sapiens	INH	%	16.0
	19147743	CHEMBL4379139	Inhibition of human recombinant ARG (48 to end residues) using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4014	Homo sapiens	IC50	uM	10.0
	19159272	CHEMBL4382376	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	50.0	CHEMBL4014	Homo sapiens	Activity	%	50.0
	19191253	CHEMBL4389572	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	97.0	CHEMBL4014	Homo sapiens	INH	%	97.0
	19191735	CHEMBL4389095	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	89.0	CHEMBL4014	Homo sapiens	INH	%	89.0
	19200024	CHEMBL4391198	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	22.0	CHEMBL4014	Homo sapiens	Activity	%	22.0
	19218927	CHEMBL4394542	Binding affinity to wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system by Kinomescan method	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	<	Kd	nM	225.0	CHEMBL4014	Homo sapiens	Kd	nM	225.0
	19266299	CHEMBL4405249	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	20598179	CHEMBL4602908	Inhibition of human ABL2	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	IC50	nM	1000.0	CHEMBL4014	Homo sapiens	IC50	uM	1.0
	20600456	CHEMBL4603293	Inhibition of recombinant full length human C-terminal His-tagged ABL2F cytoplasmic domain expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4014	Homo sapiens	IC50	uM	100.0
	22423129	CHEMBL4674140	Inhibition of human ABL2 using EAIYAAPFAKKK as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL4014	Homo sapiens	INH	%	80.0
	22423853	CHEMBL4674502	Inhibition of human ABL2 using EAIYAAPFAKKK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	48.97	CHEMBL4014	Homo sapiens	Activity	%	48.97
	22423854	CHEMBL4674502	Inhibition of human ABL2 using EAIYAAPFAKKK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	36.97	CHEMBL4014	Homo sapiens	Activity	%	36.97
	22751935	CHEMBL4700043	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)cc1		CHEMBL4792853	=	Kd	nM	31.0	CHEMBL4014	Homo sapiens	Kd	nM	31.0
	22751936	CHEMBL4700043	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system by Kinomescan method	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccc(NCCCN)cc5nc43)cc2)cc1		CHEMBL4776609	=	Kd	nM	26.0	CHEMBL4014	Homo sapiens	Kd	nM	26.0
	22751948	CHEMBL4700055	Binding affinity to ABL2 in human K562 cells at 1 mM incubated for 2 hrs by LC-MS/MS analysis based pull down assay relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccc(NCCCN)cc5nc43)cc2)cc1		CHEMBL4776609	=	FC		5.0	CHEMBL4014	Homo sapiens	FC		5.0
	22843500	CHEMBL4720496	Inhibition of ARG (unknown origin) at 1 uM relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	76.5	CHEMBL4014	Homo sapiens	INH	%	76.5
	22843501	CHEMBL4720496	Inhibition of ARG (unknown origin) at 1 uM relative to control	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Inhibition	%	38.6	CHEMBL4014	Homo sapiens	INH	%	38.6
	22843853	CHEMBL4720839	Inhibition of human ABL2 using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	10.1	CHEMBL4014	Homo sapiens	IC50	10^-8M	1.01
	22844329	CHEMBL4721192	Inhibition of human ABL2 assessed as residual activity using EAIYAAPFAKKK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	66.19	CHEMBL4014	Homo sapiens	Activity	%	66.19
	22844609	CHEMBL4721284	Inhibition of wild-type human ABL2 (A248 to G542 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	89.44	CHEMBL4014	Homo sapiens	Activity	%	89.44
	22950586	CHEMBL4766153	Inhibition of human recombinant ARG (38 to end residues) using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	4.0	CHEMBL4014	Homo sapiens	IC50	uM	0.004
	22952751	CHEMBL4766688	Inhibition of human Arg (38 to end residues) assessed as residual activity at 10 uM using EAIYAAPFAKKK as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	20.0	CHEMBL4014	Homo sapiens	Activity	%	20.0
	22969941	CHEMBL4770457	Binding affinity to human ABL2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	10.0	CHEMBL4014	Homo sapiens	Kd	nM	10.0
	23120142	CHEMBL4804336	Inhibition of ARG in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	53500.0	CHEMBL4014	Homo sapiens	IC50	uM	53.5
	23120143	CHEMBL4804336	Inhibition of ARG in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	13300.0	CHEMBL4014	Homo sapiens	IC50	uM	13.3
	23120144	CHEMBL4804336	Inhibition of ARG in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-53700.0	CHEMBL4014	Homo sapiens	IC50	uM	-53.7
	23120145	CHEMBL4804336	Inhibition of ARG in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-3000.0	CHEMBL4014	Homo sapiens	IC50	uM	-3.0
	23120146	CHEMBL4804336	Inhibition of ARG in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-2800.0	CHEMBL4014	Homo sapiens	IC50	uM	-2.8
	23120147	CHEMBL4804336	Inhibition of ARG in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	75700.0	CHEMBL4014	Homo sapiens	IC50	uM	75.7
	23121187	CHEMBL4804518	Inhibition of ARG in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	50.0	CHEMBL4014	Homo sapiens	INH	%	50.0
	23121188	CHEMBL4804518	Inhibition of ARG in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL4014	Homo sapiens	INH	%	0.0
	23121189	CHEMBL4804518	Inhibition of ARG in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4014	Homo sapiens	INH	%	0.0
	23121190	CHEMBL4804518	Inhibition of ARG in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4014	Homo sapiens	INH	%	0.0
	23121191	CHEMBL4804518	Inhibition of ARG in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4014	Homo sapiens	INH	%	0.0
	23121192	CHEMBL4804518	Inhibition of ARG in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	75.0	CHEMBL4014	Homo sapiens	INH	%	75.0
	23122430	CHEMBL4804781	Inhibition of human ABL2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	93.0	CHEMBL4014	Homo sapiens	Activity	%	93.0
	23123125	CHEMBL4805369	Inhibition of human ABL2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	98.0	CHEMBL4014	Homo sapiens	Activity	%	98.0
	23123760	CHEMBL4806004	Inhibition of DNA-tagged human ABL2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	89.0	CHEMBL4014	Homo sapiens	Activity	%	89.0
	23124340	CHEMBL4806386	Inhibition of human ABL2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	85.0	CHEMBL4014	Homo sapiens	Activity	%	85.0
	23124341	CHEMBL4806386	Inhibition of human ABL2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	91.0	CHEMBL4014	Homo sapiens	Activity	%	91.0
	23127780	CHEMBL4807735	Inhibition of ABL2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL4014	Homo sapiens	Activity	%	25.0
	23127781	CHEMBL4807735	Inhibition of ABL2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL4014	Homo sapiens	Activity	%	25.0
	23127782	CHEMBL4807735	Inhibition of ABL2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL4014	Homo sapiens	Activity	%	25.0
	23128884	CHEMBL4808082	Inhibition of ARG (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	40.0	CHEMBL4014	Homo sapiens	INH	%	40.0
	23128885	CHEMBL4808082	Inhibition of ARG (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4870763	=	Inhibition	%	32.0	CHEMBL4014	Homo sapiens	INH	%	32.0
Not Active	23317265	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	82.0	CHEMBL4014	Homo sapiens	% Control	%	82.0
Not Active	23317733	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	92.0	CHEMBL4014	Homo sapiens	% Control	%	92.0
Not Active	23318407	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	83.0	CHEMBL4014	Homo sapiens	% Control	%	83.0
Not Active	23318883	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23319523	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23319995	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23320673	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23321141	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	98.0	CHEMBL4014	Homo sapiens	% Control	%	98.0
Not Active	23321771	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23322239	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL4014	Homo sapiens	% Control	%	96.0
Not Active	23322928	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	89.0	CHEMBL4014	Homo sapiens	% Control	%	89.0
Not Active	23323396	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23323950	CHEMBL4880569	Arg (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	26.0	CHEMBL4014	Homo sapiens	% inhibition	%	26.0
Not Active	23324250	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23324885	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	99.0	CHEMBL4014	Homo sapiens	% Control	%	99.0
Not Active	23325353	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	92.0	CHEMBL4014	Homo sapiens	% Control	%	92.0
Not Active	23326000	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	87.0	CHEMBL4014	Homo sapiens	% Control	%	87.0
Not Active	23326468	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	80.0	CHEMBL4014	Homo sapiens	% Control	%	80.0
Not Active	23327168	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23327636	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23328223	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	74.0	CHEMBL4014	Homo sapiens	% Control	%	74.0
Not Active	23328691	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	87.0	CHEMBL4014	Homo sapiens	% Control	%	87.0
Not Active	23329245	CHEMBL4880952	Arg(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	93.0	CHEMBL4014	Homo sapiens	% residual kinase activity	%	93.0
Not Active	23329637	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23330105	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	93.0	CHEMBL4014	Homo sapiens	% Control	%	93.0
Not Active	23330861	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23331329	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23331916	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	67.8	CHEMBL4014	Homo sapiens	% Control	%	67.8
Not Active	23332384	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23333100	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23333739	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23334207	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23334864	CHEMBL4881488	Arg (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	37.0	CHEMBL4014	Homo sapiens	% inhibition	%	37.0
Not Active	23335186	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	86.0	CHEMBL4014	Homo sapiens	% Control	%	86.0
Not Active	23335654	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	99.0	CHEMBL4014	Homo sapiens	% Control	%	99.0
Not Active	23336281	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	98.0	CHEMBL4014	Homo sapiens	% Control	%	98.0
Not Active	23336749	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	90.0	CHEMBL4014	Homo sapiens	% Control	%	90.0
Not Active	23337505	CHEMBL4881876	ABL2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	79.5	CHEMBL4014	Homo sapiens	% Ctrl	%	79.5
Not Active	23337830	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23338298	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	84.0	CHEMBL4014	Homo sapiens	% Control	%	84.0
Not Active	23338910	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	80.0	CHEMBL4014	Homo sapiens	% Control	%	80.0
Not Active	23339378	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	88.0	CHEMBL4014	Homo sapiens	% Control	%	88.0
Not Active	23340015	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	95.0	CHEMBL4014	Homo sapiens	% Control	%	95.0
Not Active	23340483	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	93.0	CHEMBL4014	Homo sapiens	% Control	%	93.0
Not Active	23341140	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23341608	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23342224	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23342692	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23343322	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23343790	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	93.0	CHEMBL4014	Homo sapiens	% Control	%	93.0
Not Active	23344428	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	87.0	CHEMBL4014	Homo sapiens	% Control	%	87.0
Not Active	23345001	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	98.0	CHEMBL4014	Homo sapiens	% Control	%	98.0
Not Active	23345469	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23346046	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	85.8	CHEMBL4014	Homo sapiens	% Control	%	85.8
Not Active	23346515	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	98.3	CHEMBL4014	Homo sapiens	% Control	%	98.3
Not Active	23347125	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	83.9	CHEMBL4014	Homo sapiens	% Control	%	83.9
Not Active	23347606	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23348185	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23348653	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23349240	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23349858	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23350326	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23350931	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23351399	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23351954	CHEMBL4882647	ABL2 (Arg) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	0.9103	CHEMBL4014	Homo sapiens	% Inhibition	%	0.9103
Not Active	23352423	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	73.0	CHEMBL4014	Homo sapiens	% Control	%	73.0
Not Active	23352891	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23353773	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23354241	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23354973	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23355441	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23356077	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23356545	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23357154	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	82.0	CHEMBL4014	Homo sapiens	% Control	%	82.0
Not Active	23357801	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	99.0	CHEMBL4014	Homo sapiens	% Control	%	99.0
Not Active	23358269	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23358855	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	82.2	CHEMBL4014	Homo sapiens	% Control	%	82.2
Not Active	23359453	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	90.0	CHEMBL4014	Homo sapiens	% Control	%	90.0
Not Active	23359921	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	84.0	CHEMBL4014	Homo sapiens	% Control	%	84.0
Not Active	23360506	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23360974	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	95.0	CHEMBL4014	Homo sapiens	% Control	%	95.0
Not Active	23361547	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	60.0	CHEMBL4014	Homo sapiens	% Control	%	60.0
Not Active	23362083	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23362551	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23364193	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	81.0	CHEMBL4014	Homo sapiens	% Control	%	81.0
Not Active	23364661	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23365400	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23365943	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	74.0	CHEMBL4014	Homo sapiens	% Control	%	74.0
Not Active	23366533	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23367001	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	87.0	CHEMBL4014	Homo sapiens	% Control	%	87.0
Not Active	23367462	CHEMBL4883815	ABL2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	99.0	CHEMBL4014	Homo sapiens	% Residual activity with Skepinone-L	%	99.0
Not Active	23367879	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	78.0	CHEMBL4014	Homo sapiens	% Control	%	78.0
Not Active	23368347	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	88.0	CHEMBL4014	Homo sapiens	% Control	%	88.0
Not Active	23368946	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23369414	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	71.0	CHEMBL4014	Homo sapiens	% Control	%	71.0
Not Active	23369970	CHEMBL4884217	Arg(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	101.0	CHEMBL4014	Homo sapiens	% residual kinase activity	%	101.0
Not Active	23370382	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	92.0	CHEMBL4014	Homo sapiens	% Control	%	92.0
Not Active	23370850	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	99.0	CHEMBL4014	Homo sapiens	% Control	%	99.0
Not Active	23371659	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	56.0	CHEMBL4014	Homo sapiens	% Control	%	56.0
Not Active	23372127	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
	23372651	CHEMBL4884616	Arg(ABL2LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4014	Homo sapiens	pIC50		6.0
	23373060	CHEMBL4884907	Arg(ABL2LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4014	Homo sapiens	pIC50		6.0
	23373421	CHEMBL4885198	Arg(ABL2LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4014	Homo sapiens	pIC50		6.0
Not Active	23375404	CHEMBL4886386	v-abl Abelson murine leukemia viral oncogene homolog 2  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	6.0	CHEMBL4014	Homo sapiens	% inhibition	%	6.0
Not Active	23375554	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	79.0	CHEMBL4014	Homo sapiens	% Control	%	79.0
Not Active	23376022	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	93.0	CHEMBL4014	Homo sapiens	% Control	%	93.0
Not Active	23376600	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	87.0	CHEMBL4014	Homo sapiens	% Control	%	87.0
Not Active	23377069	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	85.0	CHEMBL4014	Homo sapiens	% Control	%	85.0
Not Active	23377927	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL4014	Homo sapiens	% Control	%	88.0
Not Active	23378395	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	84.0	CHEMBL4014	Homo sapiens	% Control	%	84.0
Not Active	23379562	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23380030	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23380724	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4014	Homo sapiens	% Control	%	100.0
Not Active	23381372	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	83.0	CHEMBL4014	Homo sapiens	% Control	%	83.0
Not Active	23381840	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	78.0	CHEMBL4014	Homo sapiens	% Control	%	78.0
Not Active	23382464	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	93.0	CHEMBL4014	Homo sapiens	% Control	%	93.0
Not Active	23382932	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	75.0	CHEMBL4014	Homo sapiens	% Control	%	75.0
Not Active	23383687	CHEMBL4887342	ABL2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	91.0	CHEMBL4014	Homo sapiens	% Ctrl	%	91.0
Not Active	23384180	CHEMBL4887775	Arg(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	7.75	CHEMBL4014	Homo sapiens	% inhibition	%	7.75
Not Active	23384847	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	85.0	CHEMBL4014	Homo sapiens	% Control	%	85.0
Not Active	23385314	CHEMBL4879571	KinomeScan assay: inhibition of ABL2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	84.0	CHEMBL4014	Homo sapiens	% Control	%	84.0
